Electronic system for a drug delivery device and drug delivery device

JP2023547469A5Inactive Publication Date: 2024-11-05SANOFI SA(FR)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023526227
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-10-30
Filing Date
2021-10-27
Publication Date
2024-11-05
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

An electronic system (1000) for a drug delivery device (1) is provided, the electronic system comprising: at least one user interface member (1600) configured to be operated by a user to perform a dose operation, for example a dose setting operation for setting a dose of a drug to be delivered by the drug delivery device and / or a dose delivery operation for delivering the set dose; and an electronic control unit (1100) configured to control the operation of the electronic system, the electronic system having a first state and a second state, the electronic system having a higher power consumption in the second state compared to the first state. and an electrical signal transmitting unit (1300) configured to provide an electrical signal indicating that the user interface member is being operated, wherein the electronic control unit is configured to switch the electronic system from a first state to a second state in response to the electrical signal, the user interface member includes a first portion (1603) and a second portion (1604), the first portion being movable relative to the second portion from a first portion rest position to a first portion signal transmitting position, and the signal transmitting unit is configured to provide the electrical signal in response to movement of the first portion relative to the second portion from the rest position to the signal transmitting position.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present disclosure relates to an electronic system for a drug delivery device.The present disclosure further relates to a drug delivery device, preferably a drug delivery device including an electronic system. [Background technology]

[0002] Drug delivery devices using electronic devices are becoming increasingly popular in the pharmaceutical industry and among users or patients. However, it is particularly important to integrate power resource management into the device, especially when the device is designed to be self-contained, i.e., without a connector for connecting to an external power source required to provide power for the device's operation.

[0003] An electronic system is described, for example, in US Pat. No. 6,299,649. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] EP3448470B1 Summary of the Invention [Problem to be solved by the invention]

[0005] It is an object of the present disclosure to provide a new, and preferably improved, electronic system. [Means for solving the problem]

[0006] This object is achieved by the subject matter of the independent claims. Advantageous embodiments and refinements are subject to the dependent claims. It should be noted that the present disclosure is not limited to what is claimed herein, but may include subject matter only in the descriptions that may comply with the scope of the claims.

[0007] One aspect of the present disclosure relates to an electronic system for a drug delivery device. Another aspect of the present disclosure relates to a drug delivery device, particularly a drug delivery device including an electronic system. Accordingly, features disclosed in relation to a drug delivery device or a unit therefor also apply to the electronic system, and vice versa.

[0008] In one embodiment, the electronic system includes at least one user interface member. The user interface member can be arranged or configured to be operated, e.g., touched and / or moved, by a user, e.g., a user of the drug delivery device. The user interface member can be provided for performing a dose operation, e.g., a dose setting operation for setting a dose of a drug to be delivered by the drug delivery device, and / or for performing a dose delivery operation for delivering a set dose, preferably a preset dose, during the dose setting operation. The dose operation can be an operation related to the dose to be delivered by the drug delivery device, whether a delivery operation or a dose setting operation. In addition to the dose setting operation, the dose operation can include a dose adjustment operation for increasing or decreasing the preset dose by operating the user interface member. The dose operation can be performed by a user of the drug delivery device, e.g., a patient. The dose operation can require the user to continuously contact the user interface member throughout the operation. The dose operation can involve movement of the user interface member relative to the housing of the drug delivery device, e.g., the housing of a drug delivery device unit to which the electronic system is to be connected, or the housing of the drug delivery device. Alternatively or in addition to the dose operation, the user interface member can be operated for an activation operation. The activation action may be provided as an alternative or in addition to all dose actions, i.e., the dose setting action and the dose delivery action, and, if applicable, the dose adjustment or cancellation action.

[0009] In one embodiment, the user interface member has an external operating surface positioned and configured to be touched by a user. The external operating surface can be positioned and configured to be touched during operation of the system or device, such as a dose operation, for example to initiate and / or perform an operation. Thus, the external operating surface can be or include a setting surface for a setting operation and / or a delivery surface for a delivery operation. The setting surface and the delivery surface can face in different directions. The setting surface can face radially or laterally. The delivery surface can face axially, e.g., proximally. The setting surface can extend circumferentially around the axis of the user interface member. The delivery surface can be positioned obliquely or perpendicular to the axis.

[0010] In one embodiment, the electronic system includes an electronic control unit. The electronic control unit can be configured to control the operation of the electronic system. The electronic control unit can be or include an electronic processor, such as a microcontroller or an ASIC. The electronic system can have a first state, e.g., in which the system is in a dormant or idle state, and a second state, e.g., in which the system is in an active state. The electronic system can have a higher power consumption in the second state than in the first state. In the first state, one or more electrical or electronic units of the electronic system can be in a sleep mode or can be powered down so as to consume little or no power. For example, in the second state, the motion sensing unit can be active, i.e., can operate, and in the first state, the motion sensing unit can be inactive, i.e., cannot operate. The motion sensing unit is described in more detail below. Alternatively or additionally, the communication unit can be inactive in the first state and active in the second state. The communication unit is described in more detail below.

[0011] In one embodiment, the electronic system includes an electrical signal transmitting unit. The unit can be configured to provide at least one electrical signal when the user interface member is operated. The signal can indicate that the user interface member is being operated. For example, at least one electrical signal can be initiated or generated when a user initiates or attempts to move the user interface member, e.g., relative to the housing. The electrical signal can indicate a dose operation, e.g., a dose setting operation or a dose delivery operation, or an activation operation. The signal can indicate that the dose operation has been initiated or that the activation operation has been completed. The housing can be the housing of a drug delivery device or drug delivery device unit to which the electronic system is to be connected. A movement of at least a portion or a part of the user interface member, or a movement of only a portion or a part of the user interface member, can be required to generate the respective signal, as will be described in more detail below. The signal transmitting unit can be configured to generate or provide a signal indicative of the dose operation and / or the activation operation.

[0012] In one embodiment, the electronic control unit is configured to switch the electronic system from a first state to a second state, for example, by issuing a corresponding command or signal to other units or components of the system. The electronic control unit can be configured to switch the electronic system from the first state to the second state in response to at least one electrical signal. This signal can indicate a dose operation or can require a dedicated action different from the dose operation, such as an activation action. The signal indicating an activation action can be used to selectively activate, for example, a communication unit, without activating, for example, a motion sensing unit.

[0013] In one embodiment, the user interface member includes a first part and a second part. The first part can represent or provide an external operating surface. The second part can represent or provide an interface of the user interface member to a dose setting and / or drive mechanism of a drug delivery device or drug delivery device unit. The interface can establish a permanent or non-releasable connection to the dose setting and / or drive mechanism, for example, if the system is integrated into the device, or can establish a releasable connection to the dose setting and / or drive mechanism, for example, if the system is an accessory module for the mechanism. The second part can provide a connection feature, for example, a snap feature, for connecting the user interface member to the drug delivery device unit. The system can be axially and / or non-rotatably locked to the dose setting and / or drive mechanism, for example, one of its members, by the connection. A dose operation can require movement of the second part relative to the housing. An activation operation can require movement of the first part relative to the second part, for example, from a rest position of the first part relative to the second part to a signal transmitting position of the first part. Movement of the first part to the signal transmitting position relative to the second part is required to trigger the signal transmitting unit to provide the electrical signal. The second part can be stationary during the relative movement of the first part from the rest position to the signal transmitting position. That is, the second part cannot move relative to, for example, the housing. The first part can be movable relative to the second part from the rest position of the first part relative to the second part to the signal transmitting position of the first part. The signal transmitting unit can be configured to provide the electrical signal in response to the displacement or movement of the first part from the rest position to the signal transmitting position relative to the second part. Thus, relative movement can be required to provide the electrical signal. Completing the dose operation can involve or require simultaneous movement of the first and second parts, for example, after the first part reaches the signal transmitting position relative to the second part.The rest position can be the position that the first part has relative to the second part when no force or torque is applied to the user interface member by the user. When the first part is in the rest position, the user interface member can be in an initial position, i.e., a position before a dose operation is initiated or before a dose operation can be initiated.

[0014] To activate the system, for example to wake up the system by switching it from a dormant state to a functional state, relative motion between first and second parts, both of which are part of the user interface member, is used without the involvement of a separate member to integrate into the operation of the user interface member the process of generating a signal that causes the electronic system to switch to a second state.

[0015] In one embodiment, for the activation action, the user operates a setting surface of the user interface member, preferably only the setting surface, and the activation action can involve a rotational movement of the first part relative to the second part, for example a rotational movement opposite to the dose setting direction.

[0016] In one embodiment, for the actuation action, the user operates the delivery surface of the user interface member, preferably only the delivery surface, and the actuation action can involve axial movement of the first part relative to the second part, for example axial movement in the dose delivery direction.

[0017] In one embodiment, the electronic control unit is connected, e.g., attached, to the second portion. The electronic control unit can be fixedly connected to the second portion of the user interface member. The electronic control unit can be mounted on a conductor carrier and / or conductively connected to conductors on the conductor carrier. The conductor carrier can be fixed to the second portion of the user interface member. As a result, during movement of the first portion relative to the second portion, the first portion can move relative to the electronic control unit and / or the conductor carrier. The electronic control unit is attached to a portion of the user interface member that moves relative to the first portion as it moves from a rest position to a signal-transmitting position, allowing signal generation to occur near the electronic control unit. This provides an opportunity for a short conductive path to the electronic control unit. Furthermore, the connection to the second portion ensures that the user does not have to move the electronic control unit when the first portion is moved relative to the second portion.

[0018] In one embodiment, the movement of the first part relative to the second part from the rest position to the signal transmitting position involves rotational movement of the first part relative to the second part, preferably only rotational movement, i.e., no axial movement of the first part relative to the second part. The rotational movement can occur when a user manipulates a setting surface of the user interface member, for example, for a dose setting operation or an activation operation. Such manipulation usually occurs before a delivery operation takes place, which typically involves the delivery surface being touched by the user, so that after switching to the second state, the system is given sufficient time to wake up or activate electronic components or units of the system before the delivery operation is initiated.

[0019] In one embodiment, the movement of the first part relative to the second part from the rest position to the signal transmitting position involves axial movement of the first part relative to the second part, preferably only axial movement, i.e., no rotational movement of the first part relative to the second part. In this case, the user can operate the delivery surface of the user interface member. The system can be switched to the second state just before or as the delivery operation is initiated. Thus, the electronic functions of the system can be provided only when needed, such as during the dose delivery operation.

[0020] In one embodiment, when the first portion moves from the rest position to the signal transmitting position, the second portion is stationary, e.g., relative to the housing. Movement of the second portion in the same direction as the first portion, e.g., relative to the housing, can be prevented. This prevention can be achieved, e.g., by a stop mechanism.

[0021] In one embodiment, the first and second parts must move, e.g., move relative to the housing, to effect dose actuation. The first and second parts must move simultaneously, preferably rotatably and axially, to effect dose actuation. The second part can be coupled to the first part to effect dose actuation.

[0022] In one embodiment, the forces that must be overcome to actuate movement of the second part relative to the housing, e.g., for a dose setting operation or a dose delivery operation, may include frictional forces and / or other components that need to be overcome to switch a clutch connection within the drug delivery device, e.g., a biasing force, or forces involved in activating the mechanism, i.e., before the delivery operation can begin.

[0023] In one embodiment, the first and second portions act as one integral part during dose actuation. The user interface member can act as a rigid, single member during dose actuation, i.e., there is no relative movement between the portions.

[0024] In one embodiment, relative movement, e.g., axial and / or rotational movement, between the first and second portions of the user interface member from the rest position to the signal transmitting position is restricted, e.g., unidirectional or bidirectional.

[0025] In one embodiment, to set a dose in the dose setting operation, the user interface member, e.g., the second part thereof, must be rotated relative to the housing, e.g., in the dose setting direction. This rotation can be an integer multiple of the unit setting increment angle. The unit setting increment can be the smallest dose that can be set to be delivered by the drug delivery device. The unit setting increment angle can be an angle by which the user interface member, e.g., the second part thereof and / or the first part thereof, must be rotated, e.g., relative to the housing. The angle by which the first part is rotated relative to the second part when the first part moves to the signal sending position can be smaller than the angle corresponding to one unit increment, i.e., the unit setting increment angle. For example, the angle angularly separating the rest position and the signal sending position can be smaller than or equal to half the unit setting increment angle.

[0026] In one embodiment, when the first portion rotates relative to the second portion from the rest position to the signal transmitting position, the angular distance between the rest position and the signal transmitting position is less than or equal to one of the following values: 10°, 8°, 7°, 6°, 5°, 4°, 3°, 2°, 1°. The distance can be greater than 0.5°.

[0027] In one embodiment, when the first portion moves axially relative to the second portion from a rest position to a signal transmitting position, the movement can be limited to a distance below any one of the following values: 1 mm, 0.5 mm, 0.3 mm. The movement can be 0.2 mm or greater.

[0028] In one embodiment, the distance of relative axial movement between the first and second parts from the rest position to the signal sending position may be less than the distance the user interface member must move relative to the housing to switch a clutch engagement within the dose setting and / or drive mechanism, for example to switch the mechanism from a dose setting configuration for a dose setting operation to a dose delivery configuration for a dose delivery operation, and therefore the signal sending position can be reached before the configuration of the mechanism is changed.

[0029] In one embodiment, the first and second parts are mechanically interconnected by a mechanical interconnection during a dose operation, e.g., only during a dose operation. The first and second parts can be directly interconnected by the mechanical interconnection during a dose operation. The mechanical interconnection can be configured to transmit force or torque from the first part to the second part during a dose operation. The mechanical interconnection can be a permanent connection, e.g., a connection that cannot be released without permanently destroying the functionality involved in establishing the connection, or it can be a releasable connection. Alternatively, the mechanical interconnection can be releasable. For example, the mechanical interconnection can be released when a user performs an activation operation on a user interface member to switch the electronic system from a first state to a second state. The mechanical interconnection can be established for a dose operation, e.g., a dose setting operation and a dose delivery operation.

[0030] In one embodiment, the mechanical interconnection includes at least one connecting feature. The user interface member may include multiple connecting features. The connecting features may be configured to provide the mechanical interconnection. The connecting features may be integrally formed with the first and / or second parts. The mechanical interconnection may include only one connecting feature integrally formed with the first and second parts, or may include multiple connecting features integrally formed with the first and second parts, respectively. The connecting features integrally formed with the first and second parts may be or may include webs extending between the first and second parts. The (respective) connecting features may be radially oriented. The connecting features may radially interconnect the first and second parts to each other.

[0031] In one embodiment, the transition region between the connection feature and the first portion and / or the transition region between the connection feature and the second portion can be rigid. The connection feature can be flexible. In particular, the connection feature can provide flexibility to allow movement of the first portion relative to the second portion from a rest position to a signal transmission position. The connection feature can be elastically deformable. When the first portion is moved from the rest position to the signal transmission position, the connection feature can elastically deform.

[0032] In one embodiment, the mechanical interconnection includes at least one connection feature on the first portion and at least one connection feature on the second portion. The connection features are preferably configured to interact with each other, e.g., engage with each other, to establish the mechanical interconnection. Each connection feature can be rigid. When the connection features on the first and second portions are engaged, the mechanical interconnection can be formed. When the connection features are disengaged, the mechanical interconnection can be released. The connection features can be, for example, snap features.

[0033] In one embodiment, the first and second parts are coupled via a force-sensitive coupling. This coupling can lock the parts from relative movement, for example from relative rotational movement, until a force exceeding a threshold force acts on the coupling. The coupling can then be released, allowing the first part to move relative to the second part. Forces for dose operation, for example, for setting or canceling a dose, are preferably reliably transmitted via the force-sensitive coupling. A connecting feature of the mechanical interconnection can establish the force-sensitive coupling.

[0034] In one embodiment, the system is configured such that the first portion is connected to the second portion to withstand torque and / or force after relative movement away from the rest position, e.g., into or beyond the signal transmission position, is completed, such as by rotation of less than one unit increment angle. This may be achieved by an interacting feature on the first portion abutting an interacting feature on the second portion. Thus, once the signal transmission position is reached, the mechanical interconnection cannot be further stressed to transfer loads from the first portion to the second portion.

[0035] In one embodiment, the dose operation is a dose setting operation. Alternatively, the dose operation can be a dose delivery operation.

[0036] In one embodiment, the dose setting operation involves a rotational movement of the first part in a dose setting direction relative to a housing, for example a housing of a drug delivery device.

[0037] In one embodiment, the movement of the first part away from the rest position is accompanied by a rotational movement in the dose setting direction or in a direction opposite to the dose setting direction.

[0038] In one embodiment, the second part is also moved together with the first part during the dose actuation. During the dose actuation, the entire user interface member can be moved. During the initial stage of movement for the dose actuation, the first part can be moved to a signal sending position, after which the first and second parts can be moved together. During the dose setting actuation, the entire user interface member can be moved from an initial position to a dose setting position relative to the housing. In the initial position, the first part can be in its rest position.

[0039] In one embodiment, as the movement of the first part from the signal transmission position continues in a direction away from the rest position, the first part and the second part move together, e.g., rotate together, preferably simultaneously. The signal transmission position and the direction away from the rest position can be a dose setting direction. After reaching the signal transmission position, e.g., by the first part abutting the second part, the second part can be engaged to follow the first part.

[0040] In one embodiment, the mechanical interconnection is releasable. The mechanical interconnection can be releasable to perform an activation action. The activation action can involve movement of the first part relative to the second part, in particular movement from a rest position to a signal sending position. The activation action can be different from the dose action, as already discussed above. This movement can be a rotational movement in a direction opposite to the dose setting direction.

[0041] In one embodiment, the electronic system, preferably the mechanical interconnection, is configured such that the force or torque that the user must apply to the first part by means of a user interface member to perform a dose operation, e.g., to move the first part and the second part, is less than the force or torque that the user must apply to the first part to move the first part from a rest position to a signal sending position, e.g., to perform an activation operation. The force or torque required for a dose operation can be determined by the force required to move the second part for the dose operation, e.g., relative to one or more members of the housing and / or the dose setting and / or drive mechanism. Because the mechanical interconnection must be released to move the first part from a rest position to the signal sending position, the force or torque that the user must apply for the movement to the signal sending position must be greater than the force or torque for a dose operation, in particular a dose setting operation.

[0042] In one embodiment, the electronic system, preferably the mechanical interconnection, is configured so that the force or torque that the user must apply to the first part by means of the user interface member to perform a dose operation, e.g., to move the second part together with the first part, is greater than the force or torque that the user must apply to the first part to move the first part from a rest position to a signal transmitting position.

[0043] In one embodiment, the system is configured such that when the first portion is moved from the rest position toward the signal transmitting position, the second portion is configured to abut the stop mechanism, thereby facilitating or enabling movement of the first portion toward the signal transmitting position relative to the second portion. The stop mechanism can be arranged to prevent movement of the second portion in the same direction as movement of the first portion toward the signal transmitting position. This facilitates a user applying increased force or torque to the mechanical connection, for example, by bending a connecting feature or releasing a mechanical interconnection to move the first portion toward the signal transmitting position relative to the second portion. The stop mechanism can be provided in the drug delivery device or drug delivery device unit and can, for example, be locked relative to the housing.

[0044] In one embodiment, for a dose setting operation, the first part is moved away from the signal sending position and the rest position, in which case the activation operation is preferably a different operation from the dose setting operation.

[0045] In one embodiment, for a dose setting or dose delivery operation, the first part is moved away from the rest position towards the signal sending position, in which case signal generation can be integrated into the normal dose setting operation without the need for a separate activation operation.

[0046] In one embodiment, the signal sending unit is configured to provide the electrical signal only when the first part is moved from the rest position to the signal sending position when the currently set dose size is zero. When no dose is set, the user interface member may be in a position closest to the housing, for example, a dose setting and / or dose setting configuration of the drive mechanism. Alternatively, the signal sending unit may provide the signal independent of whether a dose other than zero is currently set.

[0047] In one embodiment, the rest position is a zero dose set position or a non-dose set position of the first part and / or the user interface member. That is, in the rest position, the size of the currently set dose can be zero. The rest position can be a position of the user interface member and / or the first part that is as close as possible to the housing of the drug delivery device or drug delivery device unit, for example, when the mechanism is in the dose set configuration. For example, when the first part is in the rest position relative to the housing, the user interface member can be in an initial position until a dose setting operation is initiated.

[0048] In one embodiment, the signal sending unit includes an electrical switch mechanism. The switch mechanism may be configured to be triggered, preferably to provide an electrical signal, when the first part is moved from a rest position to a signal sending position relative to the second part. The electrical switch of the switch mechanism may be disposed on a conductor carrier and / or may be fixed to the second part. The switch may be conductively connected to the electronic control unit. The switch mechanism may be configured to distinguish between, for example, two opposite directions, such that the electronic control unit can determine the direction of rotation of the first part relative to the second part. The switch mechanism may be configured to generate signals only for unidirectional or bidirectional rotation, for example, by having multiple switches, one for each direction.

[0049] In one embodiment, the electronic system is configured such that when the first portion is in the signal transmitting position, the first portion is biased toward the rest position, for example, by a biasing mechanism of the user interface member. A user who can manipulate the user interface member can react to this bias such that the signal transmitting position of the first portion is maintained by the user. However, after the user releases the user interface member, the biasing mechanism can be configured to re-establish the relative arrangement of the first and second portions such that the first portion is again in the rest position relative to the second portion. The biasing mechanism can include an elastically displaceable or deformable feature that is elastically displaced or deformed when the first portion is moved to the signal transmitting position, thereby biasing the first portion. The elastic restoring force provided by this feature moves the first portion back to the rest position, particularly from the signal transmitting position. This feature can be, for example, a flexible arm. Alternatively or additionally, the elastically displaceable or deformable feature is a connecting feature of a mechanical interconnection.

[0050] In one embodiment, the second portion is internal to the user interface member. Preferably, the second portion is inaccessible from outside the electronic system, for example, when the electronic system is integrated into the drug delivery device or connected to the drug delivery device unit. In the electronic system, the second portion can be inaccessible from a side or proximal face of the user interface member. The second portion can be accessible from a distal end of the user interface member, for example, for connection to components of the dose setting and / or drive mechanism.

[0051] In one embodiment, the signal transmission position is angularly offset from the rest position in a direction opposite to the dose setting direction, for example, the rotation required to rotate the first part relative to the second part to the signal transmission position can be in a direction opposite to the dose setting direction.

[0052] In one embodiment, a stop mechanism may be provided to prevent rotation of the first part relative to the second part, for example past the signal transmitting position, but preferably allows limited rotatability of the first part relative to the second part.

[0053] In one embodiment, the movement of the first portion to the signal transmitting position relative to the second portion to provide the electrical signal that causes the electronic system to switch from the first state to the second state is unidirectional, thus avoiding complex multi-directional movements.

[0054] In one embodiment, the first and second portions are rigid, and the connecting feature between the portions can be flexible.

[0055] In one embodiment, the user interface member is movable, e.g., axially, from a first position to a second position relative to a housing, e.g., a housing of a system or drug delivery device. The first position can be an initial position that the user interface member has relative to the housing, e.g., before a dose delivery operation is initiated and / or after a dose setting operation is completed. The second position can be a position that the user interface member assumes when a user force, e.g., a distally directed force, is applied to the user interface member, moving it away from the first position, e.g., for a dose delivery operation. The first and second positions can be axially displaceable. Movement from the first position to the second position can involve only axial movement.

[0056] In one embodiment, the first and second parts are operably coupled to one another by a guide interface. The guide interface can be provided in addition to a connecting feature and / or a mechanical interconnection. The guide interface can guide movement of the first part relative to the second part, e.g., axially, from a rest position to a signal transmitting position. The guide interface can be configured to prevent the first part from moving at an angle relative to the second part, e.g., relative to an axis of rotation of the first part and / or the user interface member for the first movement. The axis of rotation can be an axis of the user interface member and / or an axis about which the user interface member is rotated for the dose setting movement.

[0057] In one embodiment, the electronic system or drug delivery device includes a dose setting and / or drive mechanism. The dose setting and / or drive mechanism can include a first member and a second member. The first member and / or the second member can be configured to move relative to the housing of the electronic system or drug delivery device during a dose setting operation and / or a dose delivery operation. The first member can be a dose member or a dial member, such as a dial sleeve or a number sleeve, of the dose setting and / or drive mechanism and is moved to set a dose. The second member can be a drive member, such as a dose knob and / or an injection button, engaged with the piston rod of the dose setting and / or drive mechanism or a device user interface member. The first member and / or the second member can be movably coupled to or retained within the housing. During the dose setting operation, the first member and / or the second member can be axially displaced relative to the housing, for example, away from the proximal end of the housing. The distance that the first member and / or the second member are displaced, e.g., axially, relative to the housing during the dose setting operation may be determined by the size of the set dose. In other words, the drug delivery device may be of the dial-extension type, i.e., the device increases its length during the dose setting operation by an amount proportional to the size of the set dose.

[0058] In one embodiment, during the dose setting operation and / or the dose delivery operation, the first member moves, e.g., rotates and / or moves axially, relative to the second member. For example, the first member can rotate relative to the second member during the dose delivery operation, e.g., only during the dose delivery operation. Both the first member and the second member can move axially during the dose delivery operation. The first member can rotate relative to the second member and the housing during the dose setting operation and / or the dose delivery operation. The second member can be non-rotatably locked or rotatably guided relative to the housing, e.g., by a delivery clutch, during the dose delivery operation. The first member and the second member can be non-rotatably locked relative to each other during the dose setting operation. Accordingly, the first member and the second member can rotate relative to the housing in the dose setting operation. During the dose setting operation, the first member and the second member can be coupled to each other, e.g., via a coupling interface, e.g., a setting clutch. The coupling interface can non-rotatably lock the first and second members relative to one another during a dose setting operation. When the coupling interface is engaged, the first and second members can be non-rotatably locked relative to one another, such as by direct engagement of the coupling interface features. The first and second members can include mating coupling interface features. During a dose delivery operation, the coupling interface can be released, for example, by axially displacing the second member relative to the first member. Thus, the second member can be non-rotatably locked relative to the housing during dose delivery, and the first member can rotate relative to the housing during dose delivery. The coupling interface can be released when switching the dose setting and / or drive mechanism from a dose setting configuration to a dose delivery configuration. This can be achieved when the user interface member is moved from a first position to a second position. In the first position, the mechanism can be in the dose setting configuration. In the second position, the mechanism can be in the dose delivery configuration.

[0059] In one embodiment, the first member and the second member rotate relative to each other only during one of the dose setting operation and the dose delivery operation. One of the first member and the second member, e.g., the first member, can rotate relative to the housing during both operations. One of the first member and the second member, e.g., the second member, can rotate relative to the housing only during one of these operations, e.g., during dose setting or dose delivery.

[0060] In one embodiment, the second member of the dose setting and / or drive mechanism is configured to be connected to or is connected to the second portion of the user interface member.

[0061] In one embodiment, the electronic system includes at least one, any selected number, or all of the following units or components: - An electro-motion sensing unit, which is described in more detail below. - A communication unit. The communication unit may be provided for establishing a communication interface between the electronic system and another device, e.g., a portable device, e.g., a portable or non-portable computer, a mobile phone, or a tablet. The communication unit may be a wireless unit, e.g., an RF communication unit such as a Bluetooth unit. The communication unit may be provided for transmitting dosage data, e.g., information regarding the amount of drug delivered by the device in a delivery operation, from the electronic system to the other device. - a memory unit. The memory unit may be provided for storing executable program code and / or data relating to dosage information calculated by the electronic system, preferably dosage data relating to one or more delivered doses. The dosage data may be determined via the motion sensing unit. This data may be retrievable from the memory unit for transmission, for example, via the communication unit, to another device.

[0062] In one embodiment, the motion sensing unit is configured to generate one or more electrical motion signals. The motion signals are suitable for quantifying relative motion between the first member and the second member, e.g., during a dose setting operation or a dose delivery operation, to obtain dose data, e.g., the size of a delivered dose. The first member and / or the second member can be members of an electronic system and / or a drug delivery device, e.g., a dose setting and / or drive mechanism, as further discussed above. The relative motion can be relative rotational motion. For example, the first member can rotate relative to the second member during dose delivery.

[0063] In one embodiment, the electronic system is configured such that the motion sensing unit is switched from a first state to a second state, for example, by the electronic control unit and / or in response to a signal provided by the signal transmitting unit in response to movement of the first part to the signal transmitting position. In the first state, the motion sensing unit can be inoperative to sense movement of the first member relative to the second member. In the second state, the motion sensing unit can be operable. In the second state, the motion sensing unit can have a greater power consumption than in the first state. The increased power consumption of the motion sensing unit contributes to or defines the increased power consumption of the electronic system in the second state.

[0064] In one embodiment, the motion sensing unit is configured to operate during the dose delivery operation, preferably only during the dose delivery operation. The motion sensing unit can be configured to monitor the dose delivery operation, for example the rotation of the first member relative to the second member. Thus, position information regarding the relative position between the first member and the second member can be gathered from the motion signals. Alternatively or additionally, it is also possible to gather position information between the two members during a dose setting operation. However, it is advantageous to have the motion sensing unit monitor the movement during the dose delivery operation in order to calculate dose information or data regarding dose delivery during the dose delivery operation.

[0065] In one embodiment, the electronic system is configured such that the communication unit and / or the motion sensing unit are activated in response to a signal. The communication unit can be activated in response to a dose operation and / or an activation operation, e.g., in response to the activation operation alone or in response to the activation operation and the dose operation. The communication unit can be provided to perform data transmission to an additional device, e.g., a phone or laptop, as discussed above. When the communication unit is activated, e.g., in response to an activation operation, the electronic system can attempt to transmit data, e.g., dose data, to an additional device that can be paired with the electronic system, or can synchronize data with the additional device via the communication unit. The motion sensing unit can still be in an inactive state in response to an activation operation, i.e., the motion sensing unit, in contrast to the communication unit, cannot be activated by an activation operation. The activation operation and / or the dose operation can be used to trigger data transmission or synchronization procedures with the additional device. During a dose operation, e.g., when a dose delivery operation is performed to deliver a preset dose, the motion sensing unit is preferably also in an active state. After the dose delivery operation is completed, the communication unit can transmit or attempt to transmit the data to a further device.

[0066] In one embodiment, the electronic control unit or electronic system is configured to utilize the motion signals generated by the motion sensing unit to calculate dose information or data. As mentioned above, the dose information is preferably information regarding the size of the dose delivered in the dose delivery operation.

[0067] In one embodiment, when in the rest position, the first part is movable relative to the second part in two different directions, e.g., in both rotational directions. One of these directions can be toward a signal transmission position, in which a signal is generated to switch the electronic system to a higher power consumption state, e.g., to activate the motion sensing unit and preferably the communication unit. The other direction can be away from the signal transmission position. A signal can also be generated in this direction, e.g., via a corresponding switch that, when triggered, indicates rotation in that direction. However, the electronic control unit switches the system to a higher power consumption state with the motion sensing unit active only when, and preferably only when, the signal transmission position is detected and a corresponding signal is generated. The other direction can be used to manually activate the communication unit (only), e.g., to perform a pairing or synchronization operation with another device. The operation of the user interface member associated with activating the communication unit can be an activation operation. After the motion sensing unit acquires dose data, e.g., dose data related to the dose delivered in a dose delivery operation, the pairing or synchronization operation can be integrated into the operation sequence of the electronic system.

[0068] In one embodiment, the electronic system is configured so that the electronic system switches from the first state to the second state only when the first portion of the user interface member is held, maintained, or secured away from the rest position, e.g., in a signal transmitting position, for a period exceeding a predetermined time. The predetermined period can be 2, 3, 4, or 5 seconds. Thus, for the system to switch to the second state, the first portion must be secured in the signal transmitting position, for example, against a bias that tends to move the first portion toward the rest position. This is particularly suitable for activation operations, which are different from dose operations, because activation operations require a conscious decision by the user to switch the system, and accidental movement that holds the first portion away from the rest position for a predetermined period is less likely than accidental displacement. The first portion must be rotated or axially displaced away from the rest position and secured away from that position for a predetermined period before the system can switch to the higher-power-consuming second state.

[0069] In one embodiment, the motion sensing unit includes one or more sensors and / or one or more emitters, such as one or more photoelectric emission sensors or detectors and / or one or more photoelectric emission emitters. The sensors can be configured to generate motion signals in response to movement of a first member relative to a second member. The emitters can excite the sensor signals.

[0070] In one embodiment, during the dose setting operation, the dose can be set, for example, between a settable minimum dose and a settable maximum dose, preferably in an amount corresponding to an integer multiple of one unit dose increment.

[0071] In one embodiment, the separation distance, e.g., axial separation distance, between the first and second positions of the user interface member, e.g., relative to the housing, is determined by, e.g., a clutch release distance, e.g., equal to, such a switching distance. The switching distance can be the distance that the second member of the dose setting and drive mechanism must move relative to the first member of the dose setting and drive mechanism to switch the dose setting and drive mechanism from the dose setting configuration of the mechanism to the dose delivery configuration of the mechanism. In the first position, the dose setting and drive mechanism can be in the dose setting configuration. In the second position, the dose setting and drive mechanism can be in the dose delivery configuration. For example, in the dose setting configuration or the first position, the members of the dose setting and drive mechanism can be locked against rotation, as discussed further above. In the dose delivery configuration or the second position, relative rotation is permitted, e.g., the first member can rotate relative to the second member and the housing during dose delivery. During the dose delivery operation, the second member can be locked against rotation relative to the housing.

[0072] In one embodiment, the separation distance, e.g., axial separation distance, between the first position and the second position is greater than or equal to the distance the second member must be moved, e.g., axially, relative to the first member to release the rotation lock. Specifically, the rotation lock can be released by displacing the second member axially, e.g., distally, relative to the first member during movement of the user interface member from the first position to the second position. The distance to release the rotation lock can correspond to a switching distance. Once the member is moved from the first position to the second position, a signal can be provided and / or the electronic system can be switched to the second state.

[0073] In one embodiment, the electronic system includes a power source, for example a rechargeable or non-rechargeable battery.

[0074] In one embodiment, in the second state, the electronic system is configured to collect information or data related to the size of the dose currently being dispensed or delivered during the delivery operation, e.g., via the motion sensing unit, such that the motion sensing unit can be configured to contribute to retrieving dose data related to the dose delivered in the delivery operation, e.g., the dose currently being delivered during the dose delivery operation.

[0075] In one embodiment, in the second state, the electronic system is configured to store the dose data in a dose memory or memory unit of the electronic system. The memory can be temporary or non-temporary. The dose data is preferably derived using measurements or signals of the motion sensing unit.

[0076] In one embodiment, in the second state, the electronic system is configured to transmit, by the communication unit, the dose data, e.g., the dose data retrieved from the memory, to another device or system, such as a computing device, e.g., a mobile phone or a portable or non-portable computing unit.

[0077] In one embodiment, the electronic system includes one user interface member, for example one integral member, for dose setting and dose delivery operations, or two different user interface members, one of which is the user interface member for dose setting and the other for dose delivery. The two different members are preferably movable relative to each other, for example to switch between dose setting and dose delivery configurations. If one interface member is used for dose setting and dose delivery, this interface member may have a setting surface and a delivery surface, which are preferably not movable relative to each other, in particular not movable relative to each other for or during dose delivery and / or for or during dose setting. If two different user interface members are used, the setting surface and the delivery surface may be located on different members and may be movable relative to each other for or during dose delivery and / or for or during dose setting.

[0078] In one embodiment, the electronic system includes a timer unit. The timer unit can be configured to deactivate the motion sensing unit and / or other motorized units of the electronic system after a predetermined period of time has elapsed, preferably when no motion signal is generated within this period of time. The timer unit can trigger or cause the electronic system to switch from the second state back to the first state. In other words, the electronic system can be configured to switch from the second state back to the first state when no motion signal is generated and / or received by the electronic control unit, preferably for a predetermined time.

[0079] In one embodiment, the user interface member is a dose setting and / or injection button of or for a drug delivery device.

[0080] In one embodiment, the dose setting operation and / or the dose delivery operation requires movement of the second part of the user interface member, for example relative to the housing.

[0081] In one embodiment, the electronic system includes a feedback unit. The feedback unit can be configured to generate feedback perceptible to a user. The feedback can enable the user to determine whether the system is in a first state or a second state. Preferably, in the first state, no perceptible feedback is provided, and feedback indicates the second state. The feedback can be a feedback signal, such as a light signal. The feedback signal can be provided by a light source, such as a light-emitting diode. The light source can be operated in a pulsed or flashing manner to provide the feedback.

[0082] In one embodiment, the device is a manually operated device, for example operated by a user.

[0083] In one embodiment, the drug delivery device includes a reservoir holder for holding a reservoir with the drug, e.g., a cartridge, and / or the device includes a reservoir with the drug, which reservoir can contain enough drug for multiple doses, preferably user-settable doses, to be delivered by the drug delivery device.

[0084] In one embodiment, the drug delivery device is a pen-type device.

[0085] In one embodiment, the electronic system is configured as an accessory, preferably a reusable accessory, for the drug delivery device unit. The system can be configured to be attached to the drug delivery device unit. That is, the electronic system can be configured to be used with multiple drug delivery device units. Each drug delivery device unit can be a disposable drug delivery device unit and / or each drug delivery device unit can be fully operational to perform dose setting and dose delivery operations. The drug delivery device unit can include a reservoir.

[0086] In one embodiment, the power supply is non-replaceable.

[0087] In one embodiment, a kit for a drug delivery device includes a drug delivery device unit and an electronic system. The system can be attached to the device unit to form the drug delivery device. Features disclosed above and below with respect to the drug delivery device, particularly features not directly related to the electronic system, should also apply to the drug delivery device unit, and vice versa.

[0088] As used herein, "distal" is used to designate a direction, end, or surface that is or will be positioned to face or point toward the dosing end of a drug delivery device or a component thereof, and / or points away from the proximal end, and that is or will be positioned to face away from the proximal end. On the other hand, "proximal" is used to designate a direction, end, or surface that is or will be positioned to face or point away from the dosing end and / or distal end of a drug delivery device or a component thereof. The distal end can be the end closest to the dosing end and / or the end furthest from the proximal end, and the proximal end can be the end furthest from the dosing end. The proximal face can face away from the distal end and / or toward the proximal end. The distal face can face toward the distal end and / or away from the proximal end. The dosing end can be the end of a needle, e.g., a needle unit attached or to be attached to the device.

[0089] In a particularly advantageous embodiment, an electronic system for a drug delivery device comprises: - at least one user interface member configured to be operated by a user to perform a dose operation, such as a dose setting operation for setting a dose of a drug to be delivered by the drug delivery device and / or a dose delivery operation for delivering the set dose; - an electronic control unit configured to control operation of an electronic system, the electronic system having a first state and a second state, the electronic system having a higher power consumption in the second state compared to the first state; an electrical signal transmitting unit configured to provide an electrical signal indicative of the user interface member being operated, wherein: - the electronic control unit is configured to switch the electronic system from a first state to a second state in response to the electrical signal; - the user interface member includes a first portion and a second portion, the first portion being movable relative to the second portion from a first portion rest position to a first portion signal transmitting position, and the signal transmitting unit is configured to provide an electrical signal in response to movement of the first portion relative to the second portion from the rest position to the signal transmitting position.

[0090] Configurations disclosed with respect to different aspects and embodiments can be combined with each other, even if such combinations are not explicitly discussed above or below. Further aspects, embodiments, and advantages will become apparent from the following description of exemplary embodiments taken in conjunction with the drawings. [Brief explanation of the drawings]

[0091] [Figure 1] 1 shows an embodiment of a drug delivery device or drug delivery device unit. [Figure 2] 2 is a schematic diagram of an electronic system for a drug delivery device, such as the drug delivery device of FIG. 1. [Figure 3] 2 is a schematic diagram of an embodiment of an electronic system for a drug delivery device, such as the drug delivery device of FIG. 1. [Figure 4] 4A-4H are schematic diagrams illustrating one embodiment of an electronic system for a drug delivery device, such as the drug delivery device of FIG. [Figure 5] FIG. 1 illustrates another embodiment of an electronic system for a drug delivery device. [Figure 6] 6A and 6B illustrate another embodiment of an electronic system for a drug delivery device. [Figure 7] 7A-7C illustrate another embodiment of an electronic system for a drug delivery device. DETAILED DESCRIPTION OF THE INVENTION

[0092] In the drawings, identical features, features of the same type, or features that act identically or similarly may be provided with the same reference numbers.

[0093] Some concepts are described below with reference to an insulin injection device. The systems described herein can be implemented within or used as an accessory module to this device. However, the present disclosure is not limited to such applications and can be used equally well for or in injection devices configured to deliver other medications, or in drug delivery devices in general, preferably pen-type and / or injection devices.

[0094] Provided below are embodiments related to injection devices, particularly variable dose injection devices, that record and / or track data related to delivered doses. These data may include selected and / or actual delivered dose size, date and time of administration, duration of administration, etc. Configurations described herein may include power management techniques (e.g., facilitating small batteries and / or enabling efficient power usage).

[0095] Specific embodiments are illustrated herein for an injection device that combines an injection button and a grip (dose setting member or dose setter), similar to, for example, Sanofi's ALLSTAR® device. The injection button can provide a user interface member for initiating and / or executing a dose delivery operation of the drug delivery device. The grip or knob can provide a user interface member for initiating and / or executing a dose setting operation. The device can be of the dial-extending type, i.e., the length of the device increases during dose setting. Other injection devices that have the same kinematic behavior of the dial-extending and button during dose setting and dose ejection operating modes are known, for example, the Kwikpen® or Savvio® devices sold by Eli Lilly and the FlexPen® or Novopen® devices sold by Novo Nordisk. Therefore, it is believed that applying the general principles to these devices will be straightforward, and further description will be omitted. However, the general principles of the present disclosure are not limited to their kinematic behavior. Certain other embodiments are contemplated for application to injection devices provided with separate injection buttons and grip components / dose setting members, such as Sanofi's SoloSTAR®. Accordingly, the present disclosure also relates to a system having two separate user interface members, one for dose setting and one for dose delivery. To switch between the dose setting and dose delivery configurations of the device, the user interface member for dose delivery can be moved relative to the user interface member for dose setting. If one user interface member is provided, this user interface member can be moved distally relative to the housing. During each movement, a clutch between the two members of the device's dose setting and drive mechanisms changes state, for example, from an engaged state to a disengaged state, or vice versa.For example, a clutch formed by sets of interlocking teeth on two members can lock the two members against rotation relative to one another when engaged, and can allow one of the members to rotate relative to the other when disengaged or released. One of the members can be a drive member or drive sleeve that engages with a piston rod of the dose setting and drive mechanism. The drive sleeve can be designed to rotate relative to the housing during dose setting and can be locked against rotation relative to the housing during dose delivery. The engagement between the drive sleeve and the piston rod can be a threaded engagement. Thus, since the drive sleeve cannot rotate during dose delivery, axial movement of the drive sleeve relative to the housing rotates the piston rod. This rotation can be converted into axial displacement of the piston rod during the delivery operation by the threaded connection between the piston rod and the housing.

[0096] The injection device 1 of FIG. 1 is an injection pen and includes a housing 10 containing a container 14, e.g., an insulin container, or a receptacle for such a container. The container can contain a medication, e.g., insulin. The container can be a cartridge or a receptacle for a cartridge, and the receptacle can contain or be configured to receive a cartridge. A needle 15 is attached to the container or receptacle. The container can be a cartridge, and the receptacle can be a cartridge holder. The needle is protected by an inner needle cap 16 and further protected by either an outer needle cap 17 or another cap 18. The insulin dose to be dispensed from the injection device 1 can be set, programmed, or "dialed" by turning the dose knob 12, and the currently programmed or set dose is then displayed, e.g., in multiples of units, via the dose window 13. The units can be determined only in integer multiples of one-unit set increments that can define one dose increment, by a dose setting mechanism that can enable relative rotation of the knob 12 with respect to the housing 10. This can be achieved, for example, by a suitable ratchet system. The markings displayed in the window can be provided on the number sleeve or dial sleeve 70. For example, if the injection device 1 is configured to administer human insulin, the dose can be displayed in so-called international units (IU), where 1 IU is bioequivalent to approximately 45.5 micrograms (1 / 22 mg) of pure crystalline insulin. In injection devices for delivering analog insulin or other medications, other units can also be used. It should be noted that the selected dose can be displayed equally well in ways other than those shown in the dosage window 13 of FIG. 1.

[0097] The dose window 13 may be in the form of an aperture in the housing 10 or a transparent separate component inserted into an aperture in the housing, which may incorporate a magnifying lens. The dose window 13 allows the user to view a restricted portion of the dial sleeve 70 that is configured to move as the dose knob 12 is turned to provide a visual indication of the currently programmed dose. As the dose knob 12 is turned during programming, it is caused to rotate on a helical path relative to the housing 10.

[0098] In this example, the dose knob 12 includes one or more formations 71 a, 71 b, 71 c to facilitate attachment of a data collection device or electronic system. Electronic systems that may be attachable to user interface members (knob 12 and / or button 11), or generally to elements or members of the dose setting and drive mechanism of the drug delivery device 1, are described in more detail below. The electronic system may, for example, be provided within the user interface member. The electronic system, described in more detail below, may also be configured as an accessory for the drug delivery device.

[0099] The injection device 1 can be configured so that turning the dose knob 12 produces a mechanical click sound to provide acoustic feedback to the user. In this embodiment, the dose knob or dose button 12 also acts as the injection button 11. When the needle 15 is inserted into the patient's skin area and the dose knob 12 / injection button 11 is then pressed axially, the insulin dose displayed in the display or dose window 13 is expelled from the injection device 1. When the needle 15 of the injection device 1 remains in the skin area for a period of time after the dose knob 12 is pushed back, the dose has been injected into the patient's body. The expulsion of the insulin dose can also produce a mechanical click sound, but this sound is different from the sound produced when the dose knob 12 is rotated while dialing the dose.

[0100] In this embodiment, during delivery of the insulin dose, the dose knob 12 is returned to its initial position by axial movement rather than rotation, and the dial sleeve 70 or number sleeve 70 rotates back to its initial position, displaying a dose of, for example, zero units. As previously mentioned, the present disclosure is not limited to insulin, but should encompass all drugs within the drug container 14, particularly liquid drugs or drug formulations.

[0101] The injection device 1 can be used for several injection processes until the insulin container 14 is empty or until the expiry date of the medication in the injection device 1 is reached (e.g., 28 days after first use).

[0102] Furthermore, before using the injection device 1 for the first time, it may be necessary to perform a so-called "prime shot" to ensure that fluid is flowing correctly from the insulin container 14 and needle 15, e.g. by selecting two units of insulin and depressing the dose knob 12 while holding the injection device 1 with the needle 15 pointing up. For ease of presentation, it will be assumed below that the expelled amount substantially corresponds to the injected dose, and thus e.g. the amount of medication expelled from the injection device 1 is equal to the dose received by the user.

[0103] As explained above, the dose knob 12 also functions as the injection button 11, and thus the same component is used for dialing / setting the dose and dispensing / delivering the dose. Again, it should be noted that a configuration having two different user interface members, preferably only limitedly movable relative to one another, is also possible. However, the following discussion focuses on a single user interface member providing dose setting and dose delivery functions. In other words, the setting surface of the member touched by the user for the dose setting operation and the dose delivery surface touched by the user for the dose delivery operation are immovably connected. Alternatively, if different user interface members are used, they can be movable relative to one another. During each operation, the user interface member is preferably moved relative to the device body or housing. During dose setting, the user interface member moves proximally and / or rotates relative to the housing. During dose delivery, the user interface member moves axially, e.g., distally, and preferably does not rotate relative to the housing or body.

[0104] Below, a general setup for an electronic system for a drug delivery device is disclosed.

[0105] FIG. 2 shows a schematic arrangement of elements of an electronic system 1000 that can be used in or for a drug delivery device, such as a device or device unit discussed further above, or in a different device.

[0106] The electronic system 1000 includes an electronic control unit 1100. The control unit may include a processor, e.g., a microcontroller or an ASIC. The control unit 1100 may also include one or more memory units, such as a program memory and / or a main memory. The program memory may be designed to store program code that, when executed by the system, controls the operation of the system and / or the electronic control unit. The control unit 1100 is preferably designed to control the operation of the electronic system 1000. The control unit 1100 may communicate with further units of the electronic system 1000 via a wired or wireless interface. The control unit 1100 may transmit signals containing commands and / or data to the respective units and / or receive signals and / or data from the respective units. The connections between these units and the electronic control unit 1100 are shown by lines in FIG. 2. However, there may also be connections between the units, which are not explicitly shown. The control unit 1100 may be arranged on a conductor carrier, e.g., a (printed) circuit board (see reference numeral 3000 in FIG. 3). Other units of the electronic system may similarly include one or more components disposed on the conductor carrier.

[0107] The electronic system 1000 further includes an electrical motion sensing unit 1200. The motion sensing unit 1200 may include a single sensor, e.g., only one sensor, or multiple sensors. The motion sensing unit is preferably designed to generate a motion signal, such as an electrical signal, indicative of movement of one component of the electronic system or drug delivery device relative to another component, e.g., movement of a dial sleeve or number sleeve relative to a drive sleeve or button / knob in the devices discussed further above, and the sensor may be fixedly connected to one of the components, e.g., a knob or button. The relative movement preferably occurs during a dose delivery operation. Each sensor may be an optoelectronic sensor. The optoelectronic sensor may sense radiation impinging on the sensor from a component moving relative to the sensor to excite a sensor or motion signal within the sensor, e.g., an optical encoder component. The radiation may be radiation reflected by a component from a photoelectron radiation source, e.g., an LED, and impinging on the component. The radiation source may be an IR source (IR-LED, infrared light emitting diode). The radiation source may be part of a sensor arrangement including at least one sensor. One possible embodiment of the sensor is an IR sensor configured to detect infrared light. The light source and the sensor can be located on the same component or member. The general functionality of an optoelectronic sensor arrangement suitable for the electronic systems discussed herein is disclosed in WO 2019 / 101962 A1, the entire disclosure of which is expressly incorporated herein by reference for all purposes, particularly with respect to different sensor arrangements and configurations. However, it should be noted that other sensor arrangements, such as those using magnetic sensors, can be used as well. Power consumption can be particularly high for motion sensing units having electrically powered sensors and / or electrically powered sources for stimulating the sensors, such as radiation emitters and associated sensors, and therefore appropriate power management of the power available to power the system can be particularly important.The motion sensing unit 1200 can be designed to detect, and preferably measure or quantify, the relative motion of a dose setting and drive mechanism of a drug delivery device or one component of a dose setting and drive mechanism for a drug delivery device relative to another component of the dose setting and drive mechanism or the housing 10 during a dose delivery operation. For example, the motion sensing unit can measure or detect the relative rotational motion of two movable components of the dose setting and drive mechanism relative to each other. Based on the motion data received or calculated from the unit 1200 signal, the electronic system, e.g., a control unit, can calculate dose data, e.g., data related to the currently delivered dose. The motion sensing unit 1200 is preferably configured to quantify the relative motion between a first component and a second component of the electronic system or drug delivery device. The relative motion can be indicative of the delivered dose. The relative motion can be relative rotational motion. For example, the first component can rotate relative to the second component, such as during dose delivery. The motion sensing unit is preferably suitable for quantifying the relative motion in integer multiples of one unit setting increment angle. The unit setting increment can be or can be defined by an angle greater than or equal to one of the following values: 5°, 10°. The unit setting increment can be or can be defined by an angle less than or equal to one of the following values: 25°, 20°. The unit setting increment can be, for example, 5° to 25°. The unit setting increment can correspond to, for example, a 15° relative rotation. The unit setting increment angle can be the rotation required to set the smallest dose that can be set to be delivered by the device. The increment can be defined, for example, by a ratchet system. As explained above, the amount or distance of relative (rotational) movement between the first and second members determined by the motion sensing unit is specific to the currently set dose in a dose setting operation or the currently dispensed dose in a dose delivery operation.The size of the delivered dose may be determined by or correspond to the distance that the piston rod of the dose setting and drive mechanism is displaced distally relative to the housing during the dose delivery operation.

[0108] The electronic system 1000 further includes a signal transmitting unit 1300. The signal transmitting unit may be associated with one or more user interface members (knobs 12 or buttons 11 in the device discussed above). Manipulation of a member for setting and / or delivering a dose can be detected via the signal transmitting unit 1300. The signal transmitting unit is configured to generate an electrical signal in response to manipulation of the user interface member, preferably directly in response to manipulation, e.g., unidirectional movement. The user interface member may have a setting surface arranged to be touched by a user to perform a dose setting operation and / or a delivery surface arranged to be touched by a user to perform a dose delivery operation. The setting surface may face radially, and the delivery surface may face axially, e.g., proximally. Signal generation requires movement of at least a portion of the user interface member, e.g., relative to another portion of the user interface member and / or housing. This will be further described in more detail below. The signal generating element may be an electrical sensor or switch, e.g., a micro-force switch. The signal generated by the signal transmitting unit in response to the operation can distinguish between different directions in which the user interface member is moved and / or different surfaces of the user interface member operated by the user. In this case, multiple switches can be provided. The signal transmitting unit is preferably configured such that the electrical signal it is configured to generate in response to the operation can gather information about which operation is currently being performed, intended to be performed, or has been performed, for example, a dose setting operation, a dose delivery operation, or a different operation. The signal generated by the signal transmitting unit 1300 can be a wake-up prompt signal or a usage signal. The signal transmitting unit 1300 is operably connected to, for example, the electronic control unit 1100. The signal provided by the signal transmitting unit can be received and / or processed by the electronic control unit 1100.

[0109] The electronic system 1000 further includes a communication unit 1400, e.g., an RF, WiFi, and / or Bluetooth unit. The communication unit can be provided as a communication interface between the system or drug delivery device and other electronic devices, e.g., external devices such as mobile phones, personal computers, laptops, etc. For example, the communication unit can transmit dose data to the external device and / or synchronize with the device. The dose data can be used for a dose log or dose history established in the external device. The communication unit can be provided for wireless communication.

[0110] Upon generation of the signal generated by the signal transmitting unit 1300, the electronic control unit 1100 can preferably immediately or directly switch the electronic system from a first or quiescent state (e.g., the state of the system when not needed, e.g., a sleep state; the quiescent state is optimized for power consumption) to a second state with higher power consumption, for example by activating the motion sensing unit 1200 and / or the communication unit 1400. A single signal generated by the signal transmitting unit is sufficient to trigger the switch to the second state. To switch the system to the second state, the control unit 1100 can send an activation signal to the respective units. In the second state, the motion sensing unit and / or the communication unit can be activated. In the first state, the motion sensing unit and / or the communication unit are preferably not activated. In this way, the functionality of the electric units can be available when needed. Advantageously, the power consumption required for the signal transmitting unit to be activated in the first state is less than the power consumption when the communication unit and / or the motion sensing unit are activated. The activation prompt or use signal can be generated in response to an operation of the user interface member or at least a portion thereof. The operation can involve only unidirectional movement. The operation can involve only rotational or only axial movement of the user interface member or portion. The activation operation of the user interface member can be different from the dose setting operation and the dose delivery operation. For example, the activation operation can involve a trial rotation of a portion of the user interface member in a direction opposite to the dose setting direction, e.g., at the zero dose position of the user interface member. Thus, a dedicated activation operation can be required to switch the system to the second state. Thus, the user can decide whether the electronic functions are needed or can, preferably, choose for the drug delivery device to be used without the electronic functions, e.g., in consideration of urgency or other reasons.Alternatively, signal generation can be integrated into the dose setting or dose delivery operation, for example by using relative movement between different parts of the user interface member, such relative movement preferably being limited and preferably not detectable by the user as being required to activate the electronic system.

[0111] The electronic system 1000 further includes a power source 1500, such as a rechargeable or non-rechargeable battery, which can provide power to each unit of the electronic system.

[0112] In one embodiment, the power consumption, particularly the maximum power consumption, of the electronic system in the first state, e.g., before use or generation of a wake-up prompt signal, may be less than or equal to one of the following values: 300 nA, 250 nA, 200 nA (nA: nanoamperes). Alternatively or additionally, in the second state of the electronic system, the power consumption, particularly the minimum power consumption, may be greater than or equal to one of the following values: 0.5 mA, 0.6 mA, 0.8 mA (mA: milliamperes). This difference may be due to the power consumption of the motion sensing unit 1200 and / or the communication unit 1400, which are active or operational in the second state of the electronic system 1000 and switched off or to a sleep state in the first state.

[0113] In one embodiment, the power consumption P2, e.g., minimum or maximum power consumption, in the second state may be greater than or equal to at least one of the following values: 2*P1, 3*P1, 4*P1, 5*P1, 10*P1, 20*P1, 30*P1, 40*P1, 50*P1, 100*P1, 500*P1, 1000*P1, 2000*P1, 5000*P1, 10000*P1, where P1 is the power consumption in the first state. In the second state, the motion sensing unit may be active and / or the communication unit may be active, e.g., for wireless communication.

[0114] When the system is in a first state, e.g., when neither the motion sensing unit nor the communication unit is active, the current consumption may be 200 nA. When (only) the motion sensing unit is active, the power consumption may be 0.85 mA. When, e.g., the motion sensing unit plus the communication unit are active, or when only the communication unit is active, the power consumption may be 1.85 mA.

[0115] Although not explicitly shown, the electronic system preferably includes, for example, a permanent and / or non-volatile storage or memory unit, which is capable of storing data relating to the operation of the drug delivery device, such as, for example, dosage (history) data.

[0116] In one embodiment, the electronic control unit 1100 is configured to reduce the power consumption of each unit, i.e., switch the unit back to the first state. This is appropriate, for example, if an event related to the unit, such as a motion sensing event (motion signal) for the motion sensing unit, does not occur within a predetermined time interval after the unit is switched from the first state to the second state and / or after a use signal is generated. Monitoring the time interval can be achieved by a timer unit (not explicitly shown) operably connected to the electronic control unit. If no signal is generated by the motion sensing unit within a predetermined time interval after a use or activation prompt signal, the entire system can be switched back to the first state. This time interval can be greater than or equal to one of the following values: 5 seconds, 10 seconds, 15 seconds, 20 seconds, 25 seconds, or 30 seconds. Alternatively or additionally, the time interval can be less than or equal to one of the following values: 180 seconds, 150 seconds, 120 seconds, 90 seconds, 80 seconds, 70 seconds, 60 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, or 30 seconds. The time interval can be between 5 and 180 seconds, for example, 30 seconds or 180 seconds. If no motion signal is generated within the predetermined time interval, the entire system can be switched back to the first state. The predetermined time interval is preferably constant.

[0117] In one embodiment, the electronic system includes a feedback unit (not explicitly shown). The feedback unit is configured to generate feedback perceptible to a user. The feedback can enable the user to determine whether the system is in a first state or a second state. Preferably, in the first state, no perceptible feedback is provided and / or feedback indicates the second state. The feedback can be a feedback signal, for example, a light signal. The feedback signal can be provided by a light source, such as a light-emitting diode. The light source can be operated in a pulsed or flashing manner to provide the feedback.

[0118] Each of the units described above may be integrated into a user interface member of an electronic system, which is discussed in more detail below in connection with various embodiments.

[0119] Of course, the electronic system 1000 can include additional electronic units other than those shown, such as other sensing units that sense or detect quantities or events different from the relative motion detected by the motion sensing unit.

[0120] Some more detailed embodiments of the electronic system are described below, and it should be noted that the configurations discussed above also apply to these embodiments.

[0121] FIG. 3 schematically illustrates one embodiment of an electronic system 1000. The system 1000 includes a user interface member 1600. The user interface member is designed to be operated by a user during a dose setting operation and / or a dose delivery operation. The user interface member 1600 has different external operating surfaces. These operating surfaces may be defined by an externally accessible surface of the housing or body 1605 of the user interface member, preferably when the user interface member is connected to a drug delivery device unit or integrated into a unit or device such as the device discussed in connection with FIG. 1 . The user interface member 1600 has a setting surface 1610 arranged to be grasped by a user with two fingers, e.g., an index finger and a thumb, for dose setting. The setting surface is a radially facing surface that defines the extent of the user interface member 1600 to the outside, preferably in a circumferential direction. The user interface member 1600 also has a delivery surface 1620. The delivery surface is positioned to be contacted, e.g., pressed and / or moved distally, by a user for dose delivery. Delivery surface 1620 is an axially oriented surface, e.g., a proximally facing surface. As discussed above, embodiments of the present disclosure can use different user interface members for setup and delivery.

[0122] Several additional elements or units of an electronic system are housed within the user interface member 1600, e.g., within an interior hollow defined by the user interface member body 1605. Specifically, the electronic system includes an electronic control unit 1100. The system also includes a conductor carrier 3000, e.g., a circuit board such as a printed circuit board. Conductors on the conductor carrier can conductively connect the electronic control unit to further electrical or electronic units or members of the system. The electronic control unit is disposed on, e.g., mounted to, the conductor carrier.

[0123] The electronic system 1000 includes a signal transmission unit 1300. In the illustrated embodiment, the signal transmission unit has at least one sensor or switch or multiple sensors or switches 1310. In the illustrated embodiment, the at least one switch 1310 is associated with the setting surface 1610. Alternatively or additionally, the at least one switch 1310 is associated with the delivery surface 1620. Each switch is preferably configured to generate an electrical signal or switch signal when the user interface member, or a portion thereof, is moved to perform a dose setting operation (the sensor or switch is preferably associated with the setting surface) or a dose delivery operation (the sensor or switch is preferably associated with the delivery surface). For example, for a dose setting operation, the user interface member 1600 may be rotated relative to the housing 10. Multiple switches may be provided, e.g., to enable the control unit to distinguish between different directions of rotation. For a dose delivery operation, the user interface member can be moved axially towards the housing to switch the clutch, e.g., from a state in which the dial sleeve and drive member are locked against rotation for dose setting to a state in which relative rotation is possible for dose delivery. The user interface member is preferably biased, e.g., by a clutch spring (not shown), to a position for dose setting, which position can be displaced proximally by a clutch switch distance relative to a position for dose delivery. The clutch switch distance (the distance the user interface member must be moved to switch the clutch) is, for example, 1.5 mm or more.

[0124] The electrical signal, i.e., the use or activation prompt signal, generated by the signal sending unit can directly trigger the electronic control unit 1100 to switch the system from the first state to the second state. The movement for the operation that triggers the generation of this signal is preferably unidirectional, i.e., only a movement in one direction is required. In this way, complex operations of the user interface member 1600 to switch the system to the second state can be avoided.

[0125] The system further includes a motion sensing unit 1200, represented only diagrammatically, which preferably includes one or more optoelectronic sensors and / or one or more associated radiation emitters, such as IR sensors and emitters. The motion sensing unit may be bidirectionally conductively connected to the electronic control unit 1100, as indicated by the double arrow. One direction may be the direction in which an activation signal is transmitted from the electronic control unit to the motion sensing unit. In the other direction, a motion signal may be transmitted from the motion sensing unit to the control unit, which may further process the signal, for example, to calculate dosage information or data. The motion sensing unit 1200 may be located on the side of the conductor carrier 3000 facing away from the control unit 1100.

[0126] The system 1000 further includes a power source 1500, e.g., a battery such as a coin cell. The power source can be configured to provide a total charge of approximately 25-500 mAh at a voltage of approximately 1.4-3 V. This can be achieved or assisted, for example, by stacking multiple coin cells. The power source 1500 is conductively connected or connectable to other components of the electronic system that require power for operation. The conductive connection is not explicitly shown in FIG. 3 . A metal stamping can be provided to connect the power source 1500 to the conductor carrier 3000, which can distribute power to additional elements via conductors on the carrier. However, the power source can be positioned to extend along one major surface of the conductor carrier 3000, as shown. In the illustrated embodiment, the power source is positioned between the conductor carrier 3000 and the delivery surface 1620. This facilitates the formation of a compact user interface member 1600.

[0127] The radial width or diameter of the user interface member 1600 as viewed from the exterior of the member, e.g., in a top view of the delivery surface, can be less than or equal to one of the following values: 2 cm, 1.5 cm. Alternatively or additionally, the radial width or diameter of the user interface member can be greater than or equal to one of the following values: 0.5 cm, 0.7 cm. The radial extension can be determined relative to the axis of rotation of the user interface member during dose setting or the main longitudinal axis of the user interface member, and these axes can be coincident. The length or axial extension of the user interface member 1600 can be less than or equal to one of the following values: 2.5 cm, 2 cm, 1.5 cm. Alternatively or additionally, the length or axial extension of the user interface member 1600 can be greater than or equal to one of the following values: 0.5 cm, 0.7 cm.

[0128] The electronic system 1000 is configured to be connected, preferably releasably connected, to a drug delivery device unit that is an accessory unit or module. The drug delivery device unit may not include electronics. Accordingly, all electronics may be provided within the electronic system. The drug delivery device unit may be disposable, i.e., the unit may be discarded after the unit's reservoir is emptied using a drug delivery device that includes the unit and system 1000. The electronic system 1000 may also be reused for another drug delivery device unit. The drug delivery device unit is preferably configured as a fully functional unit, i.e., capable of operating to set a dose to be delivered and deliver the set dose. One exemplary unit is the unit shown in FIG. 1. The electronic system may be a pure accessory to an otherwise fully functional unit and preferably does not include electronic or electrically powered components. Alternatively, the drug delivery device may include the electronic system as an integral part, i.e., a part that is discarded with the rest of the device and / or a part necessary to operate the device to set and deliver a dose of drug. For example, without the electronic system, the drug delivery device unit would lack a user-accessible surface for performing dose setting or dose delivery operations. For connection to the drug delivery device unit, the electronic system may include one or more connection features 1615, e.g., snap features. Each connection feature may be located within a distal portion of the user interface member 1600, e.g., within the member.

[0129] The system 1000 is preferably configured to be permanently or detachably / releasably mechanically connected to a member of the dose setting and drive mechanism, e.g., a member of the drug delivery device unit, such as the drive sleeve or dose knob and / or injection button of the unit discussed in connection with FIG. 1 . The system can be non-rotatably and axially locked to the member of the drug delivery device unit, e.g., via the user interface member body 1605. The member to which the system is connected can be movable relative to the housing 10 during dose setting and / or dose delivery, e.g., rotatably and / or axially movable during setting and only axially movable during delivery. The member can engage, e.g., threadably engage, the piston rod. The dose knob and drive sleeve of the unit of FIG. 1 can be integrally formed or can act as a single member during dose setting and dose delivery. During dose setting, the drive sleeve can be selectively non-rotatably locked to the dial sleeve of the dose setting and drive mechanism, e.g., by a clutch, so that the dial sleeve and drive sleeve rotate at the same speed during dose setting and the dial sleeve rotates relative to the drive sleeve during dose delivery. The dial sleeve can be a number sleeve. Relative rotation between the dial sleeve and the drive sleeve during dose delivery can be measured by a motion sensing unit. However, it will be readily apparent to one skilled in the art that the disclosed concepts also function as dose setting and drive mechanisms having different operating methods and / or different configurations.

[0130] The following embodiments illustrate example implementations of the signal sending unit 1300. In each case, the signal sending unit is configured to provide or generate a signal, e.g., a use signal or an activation prompt signal, in response to movement of a first portion of the user interface member 1600 relative to a second portion of the user interface member. The first and second portions are preferably connected or fixed to each other so as to operate as one member in addition to the movement required to generate the signal, and preferably to re-establish the original relative position between the two portions. For signal generation, limited relative mobility between the portions of the user interface member is utilized.

[0131] 4 illustrates one embodiment of an electronic system 1000 based on various schematic diagrams in different views shown in FIGS. 4A-4H. Generally, the system corresponds to the systems previously described. Therefore, unless stated otherwise or to the contrary, the features already discussed also apply to this embodiment.

[0132] The electronic system 1000 according to this embodiment includes a signal transmitting unit 1300. The signal transmitting unit 1300 includes a setting signal transmitting unit. The setting signal transmitting unit is configured to provide a signal indicating that a dose setting operation has been initiated or performed by a user using the user interface member 1600. The setting signal transmitting unit includes a setting switch 1660. The setting switch 1660 is associated with a setting surface 1610 of the user interface member 1600. Alternatively or in addition to the setting signal transmitting unit, the signal transmitting unit includes a delivery signal transmitting unit. The delivery signal transmitting unit includes a delivery switch 1650. The delivery switch 1650 is associated with a delivery surface 1620 of the user interface member 1600. The delivery signal transmitting unit is provided to provide a signal in response to operation of the delivery surface. The setting signal transmitting unit is provided to provide a signal in response to operation of the setting surface. A dose setting operation can be detected via the setting signal transmitting unit. A dose delivery operation can be detected via the delivery signal transmitting unit. If only one of the delivery or set signal transmitting units is provided, only one of the set or deliver operations can be detected; if both units are provided, both the set and deliver operations can be detected. The electronic system can be configured to operate differently in response to a signal indicating a set operation (set signal) and a signal indicating a deliver operation (delivery signal). Each switch 1650, 1660 can be an electrical switch, e.g., a microswitch such as a force switch. An additional set switch (not shown) can also be provided that enables the system to distinguish between different rotation directions.

[0133] 4A illustrates, based on an expanded view, some of the elements of user interface member 1600. It should be noted that FIG. 4 does not necessarily illustrate all components or elements of the electronic systems discussed above and below, but rather only the most important elements relevant to the concepts discussed.

[0134] The user interface member body 1605, in the illustrated embodiment, includes a first member 1601 and a second member 1602. In operation, the two members are preferably rigidly connected to act as a single member, at least externally, during dose setting and dose delivery operations. The outer surface of the user interface member can be rigid. That is, the portion of the outer surface formed by the first member and the portion of the outer surface formed by the second member can be non-rotatably and axially fixed to one another, e.g., by welding, such that relative movement between them is not possible. The first member 1601 can provide a delivery surface 1620. The second member 1602 can provide a setting surface 1610, or at least a majority of it. As shown, the first member 1601 can provide the delivery surface 1620 and / or radially oriented and circumferentially arranged regions of the setting surface 1610. Multiple members of the user interface member 1600 can be provided for manufacturing reasons. A unitary construction of the user interface member body 1605 is also possible.

[0135] The conductor carrier 3000 is again disposed within the user interface member body 1605. The conductor carrier 3000 may be rigidly connected to the user interface member. The electronic control unit 1100 is not shown in FIG. 4 for illustrative purposes, but may nevertheless be disposed within the user interface member 1600, particularly on the conductor carrier 3000, as well as the remaining components or units further described above.

[0136] The arrangement shown in FIG. 4 further includes a member 3010. The user interface member body 1605 can be fixed to the member 3010, for example, permanently or releasably. The member 3010 can be a sleeve. The member 3010 can be, for example, a member of a drug delivery device unit to which the electronic system can be fixed as an accessory module, or a member of a drug delivery device to which the electronic system is a part. The member 3010 can be, for example, a drive sleeve or a dose knob of a dose setting and drive mechanism. The member 3010 can be rigidly connected to the user interface member, in particular the user interface member body, for example, axially and / or rotatably. The user interface member 1600 can be rigidly connected to the member 3010 via a connection interface 3020 (see FIG. 4D), for example, a snap fit, such that relative rotational and axial movement between the member 3010 and the user interface member 1600 is prevented. As a result, axial forces and rotational torques can be transmitted from the user interface member to the member 3010 via the connection interface 3020. The member 3010 can protrude distally from the setting surface 1610 .

[0137] Figure 4B shows the user interface member 1600 when assembled from a perspective view. Figure 4C shows a top view of the delivery surface 1620 of the user interface member 1600. Figure 4D shows a cross-sectional view taken along line BB in Figure 4C.

[0138] The user interface member 1600 includes a first portion 1603 and a second portion 1604. The first portion 1603 provides at least one outer surface of the member, such as a setting surface or a delivery surface, or both. The second portion 1604 provides an interface to a drug delivery device (unit), represented schematically by the member 3010. Thus, a mechanical connection to the mechanism can be achieved through the portion to which the conductor carrier 3000 is fixed. Each portion 1603, 1604 can be rigid. That is, each portion can be provided to withstand a mechanical load, such as a force or torque, and can be configured to transmit the load, for example, to a dose setting and / or drive mechanism. This load can be a load for a dose setting and / or dose delivery operation. This load can be a load generated by a user acting on the delivery or setting surface. The first portion 1603 can have a continuous portion extending circumferentially around a central major axis of the user interface member 1600, which can form a setting surface. The first portion 1603 can also have a radially extending interconnected portion connected to the continuous portion on an opposite side of the central major axis, which can form a delivery surface 1620. The second portion 1604 is radially and / or inwardly offset relative to the setting surface 1610. The second portion 1604 can be distally offset relative to the delivery surface 1620. A space can be formed between the inner wall facing the delivery surface and the second portion. The first portion 1603 can define the interior space of the user interface member 1600 and / or can delimit the member relative to the exterior. The second portion can be only partially, as shown, or completely disposed in the interior space. The radially outer surface of the second portion can face the radial surface of the first portion. When the user interface member 1600 is connected to the member 3010, the major axis 1613 of the user interface member can be the axis about which the user interface member rotates relative to the housing 10 of the device (not shown). The first portion 1603 and the second portion 1604 can be oriented along the axis 1613.

[0139] The first part 1603 and the second part 1604 are connected to each other via a connecting part 1606 or connecting feature. The connecting part 1606 is radially oriented, e.g., a web. The connecting part can have a radial main extension direction. The first part 1603 or at least a part thereof (see further above), the connecting part 1606, and / or the second part 1604 can be integrated into a unitary structure, e.g., a plastic and / or molded structure. The connecting part is rigidly connected to the first part and the second part.

[0140] The connecting portion 1606 is deformable, preferably elastically deformable, to allow the first portion 1603 to move, for example, in a limited manner, relative to the second portion 1604. The connecting portion can be angularly or rotationally deformable and / or axially deformable. Axial deformability is particularly suitable for a delivery signal sending unit, while angular or rotational flexibility is particularly suitable for a setting signal sending unit. When the first portion 1603 is moved relative to the second portion 1604 and the associated switch 1650 or 1660 is triggered during this movement from the rest position to the signal sending position, a signal can be generated to indicate the respective operation. In response to this signal, the electronic control unit 1100 preferably switches the electronic system to a state of higher power consumption, as previously discussed. To allow axial deformation in the distal direction, an axial space 3030 can be provided between the member 3010, particularly its proximally facing surface, and the connecting portion 1606, as is apparent from FIG. 4D . Alternatively or additionally, for axial deformability, an axial space exists between the first and second portions, for example, between the distally facing surface of the first portion and the proximally facing surface of the second portion. However, other configurations may be suitable. Angular flexibility can be facilitated by an angular space 1607 between the connecting portion 1606 and a region of the second portion 1604. The angular space can be located on both sides of the connecting portion 1606 or on only one side. This is evident from FIGS. 4E and 4F, which show cross-sectional views taken along the indicated lines in FIG. 4G. FIG. 4H shows a cross-sectional view taken along line CC in FIG. 4D. The connecting portion 1606 enables limited movement of the first portion 1603 relative to the second portion 1604.

[0141] The first portion 1603 is preferably axially guided relative to the second portion 1604, e.g., to avoid tilting during (limited) relative axial movement. For this purpose, a guide feature 1609 of the first portion 1603, e.g., a pin-like feature and / or a feature protruding axially (distally) from an inner surface, may be provided, preferably at the proximal end of the user interface member 1600. The guide feature 1609 interacts with a corresponding guide feature 1608 of the second portion 1604, which preferably defines a guide opening. The axial guide interface established between the guide feature and the corresponding guide feature preferably enables relative axial and / or rotational movement between the first portion 1603 and the second portion 1604. The guide features 1608 and 1609 may be in radial frictional contact with each other to provide the guide function.

[0142] Due to the flexibility provided by the connecting portion 1606, the user interface member 1600 is designed so that a force or torque applied by the user to the setting surface and / or delivery surface moves the first portion 1603 relative to the second portion 1604 before the load applied by the user is transmitted to further components or members of the dose setting and drive mechanism via the user interface member, particularly its second portion 1604. In the case of operation of the setting surface 1610, the movement of the first portion is, for example, a rotation in the dose setting direction or the opposite direction, where the dose setting direction is the direction required to increase the size of the set dose. Thus, the play between the first and second portions can be used to generate a use signal or activation prompt signal, such as a set signal or a delivery signal, depending on whether the set switch 1660 or the delivery switch 1650 is triggered. Of course, if only the set or delivery switch is present, only the set or delivery signal can be generated. The respective signal can be used to trigger an electronic control unit to switch the electronic system to a state with higher power consumption. After the relative movement of the first portion relative to the second portion from the rest position is completed, the first and second portions can move simultaneously away from the rest position of the first portion, e.g., in a dose setting direction to set a non-zero dose, or in a distal direction to deliver a dose. Alternatively, an actuation action distinct from a dose action, e.g., as opposed to a dose setting action, can be used to generate the above-mentioned signal.

[0143] When viewed along the force transmission path from the external surface that is manipulated by the user to apply a force to a member 3010 that preferably belongs to the dose setting and drive mechanism, the first portion 1603 is closer to the user than the second portion 1604. The connecting portion 1606 is located between the two portions when viewed along the force transmission path. In the illustrated embodiment, the first portion provides the surface that interfaces with the user and the second portion provides the interface to the dose setting and drive mechanism of the drug delivery device unit or drug delivery device.

[0144] The conductor carrier 3000 is axially and / or non-rotatably fixed to the second portion 1604. As a result, the switches 1660 and 1650 are fixed to the second portion 1604. Features arranged to trigger the respective switches can be provided on the first portion 1603. In the illustrated embodiment, an interface feature, e.g., a distally directed protrusion 1655, is arranged to engage a trigger feature 1657 of the delivery switch 1650. When the delivery surface 1620 is depressed to initiate a delivery operation, a force (axial or distally directed) is transmitted through the interface feature 1655 to the trigger feature 1657 due to the axial flexibility provided by the connecting portion 1606, and through the trigger feature to a load sensing component of the switch 1650, causing the switch to generate a signal (in this case, a delivery signal). The delivery signal is preferably generated before the clutch interface is switched, e.g., disengaged. For example, the signal can be generated before the member 3010 disengages the dial or number sleeve for a dose delivery operation, with the member 3010 and dial or number sleeve locked against rotation during a preceding dose setting operation to set the dose to be delivered. The setting switch 1660 includes an interface feature 1665, e.g., a recess, such as a radially oriented recess, provided on an inner surface of the first portion 1603. The interface feature 1665 is positioned to engage a trigger feature 1667 of the switch 1660. When the user interface member 1600 is rotated via the setting surface 1610, initial relative motion between the first portion 1603 and the second portion 1604 transmits a load via the trigger feature 1667 to a load sensing component of the switch 1660, causing the switch 1660 to generate a signal (in this case, a set signal).

[0145] The relative movement between the first part 1603 and the second part 1604 required to trigger the switch can be less than the rotational movement required to set a one unit increment dose and / or the axial movement required to switch the state of the clutches within the dose setting and drive mechanism, e.g., to disengage two clutch components or to engage two clutch components, which switches the mechanism from a dose setting configuration to a dose delivery configuration. After the user-applied load is removed from the respective surfaces of the first part, the resilience of the connecting parts can re-establish the initial state, i.e., the initial or first relative position between the first part and the second part.

[0146] 4D-4G show the initial arrangement. From the situation in FIG. 4F, when a dose is set by rotating the user interface member relative to the housing, the first part initially rotates relative to the second part, e.g., clockwise and / or in the dose setting direction. During this phase, a signal can be generated by switch 1660. Also, space 1607 can be closed or at least reduced, e.g., until connecting part 1606 abuts second part 1604. After the signal is generated, both parts 1603 and 1604 can rotate at the same speed away from the signal transmission position until the desired dose is set. For the delivery operation, relative axial movement between the first and second parts can trigger signal generation via switch 1650.

[0147] In the illustrated embodiment, the carrier 3000 reacts to axial forces during the delivery operation. As a result, the entire dosing force may need to act on the carrier. If axial abutment between the first and second portions is established after the first portion is displaced relative to the second portion to trigger the switch 1650, this can be avoided or at least its effect on the carrier 3000 can be reduced. Axial abutment can be achieved, for example, by one or more protrusions projecting radially from the guide feature 1609 outward from the guide opening (not explicitly shown), with the distal-facing surface of each protrusion positioned to abut the proximal-facing surface of the second portion 1604. Similarly, after the relative motion between the two portions to generate the signal is complete, rotational abutment between the first and second portions can be provided by two surfaces facing each other angularly. This prevents excessive loads from acting on the connection, which is particularly susceptible to damage due to its flexibility. In other words, after the relative movement (axial and / or rotational movement) between the first and second parts is completed, a driven interface can be formed between the first and second parts for further movement of the first part away from its resting position relative to the second part, and the driven interface couples the second part to the first part in a direction defined by the movement of the first part towards the second part, e.g., a dose setting direction or a distal direction for dose delivery.

[0148] The relative rotational or angular movement between the first and second parts required to generate a signal (e.g., a setting signal) can be less than or equal to an angle corresponding to a one-unit setting increment (e.g., 15°). For example, the relative rotational or angular movement between the first and second parts required to generate a signal can be less than or equal to one of the following values: 15°, 10°, 9°, 8°, 7°, 6°, or 5°. Alternatively or additionally, the relative rotational or angular movement between the first and second parts required to generate a signal can be greater than or equal to one of the following values: 1°, 2°, 3°, or 4°. The relative axial movement between the first and second parts required to generate a signal (e.g., a delivery signal) can be less than or equal to one of the following values: 1 mm, 0.9 mm, 0.8 mm, 0.7 mm, 0.6 mm, or 0.5 mm. Alternatively or additionally, this movement can be greater than or equal to one of the following values: 0.2 mm, 0.3 mm, 0.4 mm. Consequently, the angular or axial distance between the abutment feature on the first part and the corresponding abutment feature in the second part can exhibit a corresponding value, particularly starting from an initial state or configuration between the first and second parts prior to relative movement. The relative axial movement between the first and second parts required to trigger a signal can be, for example, 0.5 mm (i.e., the axial separation between the first and second positions). The relative angular movement between the first and second parts required to trigger a signal can be, for example, 4° (i.e., the angular separation between the first or rest position and the second or signal-transmitting position). Having the relative rotational or angular movement between the first and second parts required to generate a signal less than half the angle corresponding to the unit setting increment (which can be 15°) has the advantage that signal generation can be easily integrated into the dose operation.Having the relative rotational or angular movement between the first and second parts required to generate a signal be greater than half the angle corresponding to a unit setting increment has the advantage that it can give the user the impression that they are doing something significant. Thus, the rotation to generate the signal can be, for example, 10°. This is particularly suitable for activation operations that are different from the dose setting operation, for example in the direction opposite to the dose setting direction.

[0149] Setting the angle for generating the signal smaller than the angle of the unit setting increment can be advantageous because it allows for a smaller rotational movement to trigger a signal for the user. However, it should be noted that rotations greater than an angle corresponding to one unit setting increment, e.g., 20°, are also contemplated for generating a signal. The user can verify the current dose, set, for example, via the number sleeve, via the dose display. Therefore, in this regard, it does not matter if the relative rotation between the first and second parts is greater than an angle corresponding to one unit setting increment for generating a signal.

[0150] By integrating the connecting portion 1606 into the user interface member, the user can operate the user interface member without any hint to the user that relative movement between portions of the user interface member is used to control or switch the state of an electronic system, such as switching a component or unit of the system to a state of higher power consumption.

[0151] In one embodiment, the first part is movable relative to the second part in two opposite directions, e.g., axially and / or rotationally. The signal-sending unit can be configured to provide an electrical signal only during movement in one or both of these directions. When signals are provided in two opposite directions, one of these directions, e.g., the dose-setting direction, can be used to provide a wake-up prompt or usage signal to switch the system to a higher power-consumption state. The other direction can be used for a different purpose, e.g., to provide a signal to initiate a synchronization process of dose data to another electronic device, such as a computing device, preferably a mobile phone or a server. Synchronization can be performed by a wireless interface established between the electronic system and the electronic device via the communication unit. This can be an option for the user to manually trigger the synchronization process by a wake-up action. The synchronization process, or an attempt to perform such a process, can be integrated by default into the operating routine of the electronic system after a dose-delivery action has been performed and the motion-sensing unit has generated data.

[0152] When rotation opposite to the dose setting direction is used for signal generation, for example to manually trigger a synchronization event, the first part can be rotated against a zero dose stop or zero unit stop, which can engage the second part to prevent rotation of the second part in the same direction as the first part, thereby enabling rotation of the first part away from the second part.

[0153] Using rotational motion to generate one or more signals indicative of manipulation of a user interface member, and in response to each signal an electronic system performs an action or changes its state, can be advantageous over using axial motion (only) for this purpose, since the user interface member is less likely to be accidentally rotated than accidentally displaced axially.

[0154] If a setting signal transmitting unit and a delivery signal transmitting unit are provided, the setting signal transmitting unit can be used to activate the electronic control unit, for example, to switch from a sleep state to a state with higher power consumption, while the motion sensing unit and / or communication unit are not yet active. Additional units can be activated by the delivery signal transmitting unit. Naturally, it is also possible to provide only a setting signal transmitting unit or a delivery signal transmitting unit. When the system is switched to the second state with higher power consumption by the setting signal transmitting unit, the time for the delivery operation, i.e., the time during which the motion sensing unit must perform dose setting and record or generate data regarding the relative motion between elements of the drive mechanism, is greater than the time during which the delivery signal transmitting unit is used for this purpose. However, the delivery signal transmitting unit typically operates closer to the delivery operation than the setting signal transmitting unit. Therefore, when the delivery signal transmitting unit is used to switch the electronic system to the second state, unnecessary switching to the second state is unlikely to occur, since some users may play around by rotating the user interface member in opposite directions to set and cancel doses rather than actually performing the delivery operation or operating the delivery surface. By utilizing relative motion during setting or delivery, signal generation is seamlessly integrated into the dose setting or dose delivery operation.

[0155] The electronic system 1000 can be configured such that a signal from the delivery signal transmitting unit is only considered, for example, by the control unit, if a setting event is determined via the setting signal transmitting unit, preferably within a predetermined time interval, such as less than one of the following values, before the signal from the delivery signal transmitting unit: 5 minutes, 3 minutes, 2 minutes, 1 minute, 45 seconds, 30 seconds, 20 seconds, 15 seconds. Also, after a setting event is detected by the switch 1660, the delivery switch 1650 can be switched to a higher power consumption state. Furthermore, if a user applies simultaneous load to both surfaces, i.e., the setting surface and the delivery surface, which involves the generation of setting and delivery signals, the electronic control unit can issue a corresponding signal, record a corresponding event, or generate an alert indicating that the system may have been improperly handled when loads were provided to both surfaces simultaneously.

[0156] It should be noted that instead of having a unitary portion of the user interface member connecting the first and second portions, with all portions integrally formed with one another within a unitary structure, signal generation can also be achieved by having two separate members of the user interface member that are movable relative to one another, for example, before setting the first unit setting increment is complete, before delivering the dose, and / or before switching the clutch interface. These members can be spring biased to allow the relative movement required for signal generation. However, a unitary structure is preferred because a user is less likely to notice the multi-member structure when operating the user interface member.

[0157] 5 shows another embodiment of an electronic system for a drug delivery device. In this embodiment, similar to the previous embodiment, a setting signal sending unit (represented by switch 1660) is provided, which generates a signal upon operation (rotation) of the setting surface, which involves relative rotation between the first and second parts. The signal can preferably directly trigger the electronic control unit 1100 to switch the electronic system to the second state. This embodiment is very similar to the embodiments already discussed, so the following description will focus on the differences.

[0158] Rotation of the first portion 1603 relative to the second portion and switch 1660 (which may again be a rotatably operated force or torque switch) in one rotational direction triggers signal generation. Note that when the first portion 1603 is rotated in a first rotational direction, here clockwise, the trigger feature 1667 preferably immediately transmits a load (force or torque) to the switch 1660 due to angular abutment between the first portion 1603 and the trigger feature 1667. Rotation of the first portion in a second rotational direction opposite the first rotational direction relative to the first portion does not result in signal generation because no load is transmitted to the trigger feature 1667 due to, for example, the interface feature 1665 allowing relative rotation before angular abutment with the trigger feature 1667 is established. Thus, an angular gap occurs in the second rotational direction. Preferably, the second portion rotatably couples to the first portion in the second direction until a signal is generated. It should be noted that in addition to the rotational gap, signal generation in the direction opposite to the first direction can also be prevented by various other measures. The first rotational direction that generates the signal can be the dose setting direction, i.e., the direction in which the user interface member is rotated when the set dose is increased. Alternatively, the first rotational direction can be the opposite rotational direction. In this case, an activation action is used for signal generation that is different from the dose setting and dose delivery actions, which can be advantageous as well.

[0159] Thus, in this embodiment, the user interface member 1600 can selectively generate a signal, i.e., only when the user interface member is rotated in a first rotational direction. Such directional selectivity can also be applied to the previously discussed embodiments.

[0160] 6A and 6B illustrate another embodiment of an electronic system. Generally, this embodiment is very similar to the embodiment discussed in connection with FIGS. 4A-4H . Therefore, the following discussion will focus on the differences. This embodiment also uses two portions 1603 and 1604 of a user interface member 1600 connected to each other via a connecting portion 1606. Unlike the previous embodiment, the connecting portion 1606 has multiple regions 1670 and 1680. Each region extends radially and / or connects the first portion 1603 to the second portion 1604. These regions can be webs. These regions are axially offset from each other. Regions 1670 and 1680 are axially separated from each other by a space or gap 1675. The detail shown in FIG. 6B illustrates the (axial) flexibility of the connecting portion 1606, which involves deformation of both regions. The space or void 1675 can have a cross-section shaped according to a rectangular or non-rectangular parallelogram, for example, taken along a major axis of the user interface member. This can help to avoid undesired tilting movement of the user interface member 1600 in the radial and axial directions relative to the shaft and / or member 3010. Accordingly, this embodiment does not require further guiding features as described above. Therefore, in the illustrated figures, guiding features 1608 and 1609 are not provided.

[0161] 7A-7C show another embodiment of the electronic system. Generally, this embodiment is similar to the previously described embodiment, and therefore features disclosed in this context may also apply to this embodiment, particularly if they do not contradict what is discussed below. In the previously described embodiments, signal generation by the signal-sending unit may be associated with an operation or action directly associated with and / or integrated with a dose setting operation and / or a dose delivery operation, e.g., a unidirectional movement of a user interface member required for these operations. In this embodiment, a separate user action, i.e., a wake-up action distinct from the dose setting operation and the dose delivery operation, is required to generate a signal, particularly to switch the electronic system to a state with higher power consumption, e.g., when the motion sensing unit and / or the communication unit are in an operational state.

[0162] 7A , the user interface member 1600 is shown in a schematic cross-sectional view. The user interface member 1600 again has a first portion 1603 and a second portion 1604. A conductor carrier 3000 is provided inside the user interface member 1600. An electrical switch 1685 for the signal transmitting unit 1300, such as a microswitch such as a micro-force switch, is disposed on the carrier 3000. The switch 1685 has a trigger function 1687 that triggers the switch to generate a signal when exposed to force. The carrier may again be a printed circuit board or another conductor carrier. The switch 1685 is disposed below the delivery surface 1620. The signal transmitting unit 1300 is configured to generate a signal when the first portion 1603 rotates relative to the second portion 1604. The switch 1685 is operably coupled to the electronic control unit 1100, which is also housed within the user interface member body 1605. In the illustrated situation, the control unit 1100 and the signal transmitting unit, particularly the switch 1685, are electrically connected to and / or mounted on different conductor carriers, i.e., the unit 1100 is connected to a separate conductor carrier 3005 from the switch 1685. The conductor carrier 3005 is also mounted inside the user interface member body 1605. The conductor carriers 3000 and 3005 are preferably electrically interconnected by conductors, such as, for example, metal stamping components. The conductor carriers can be arranged stacked and / or parallel. In this way, a signal triggered by the switch 1685 can be detected or processed by the control unit 1100. A power source 1500, for example, a coin battery, is disposed on the side of the conductor carrier facing away from the delivery surface 1620 and / or between the two conductor carriers 3000 and 3005. Each carrier is preferably fixed to the second portion 1604 of the user interface member 1600. The second portion 1604 can have multiple members (as shown) fixedly fastened together or only one member. The same is true for the first portion (not shown).If the second part is formed from different members, one carrier can be fixed to one of these members and the other carrier can be fixed to the other of these members. However, it should be noted that the electronic control unit 1100 and the signal transmitting unit 1300 or the switch 1685 can also be located on the same carrier. As already discussed further above, when the switch 1685 is triggered, it can wake up and / or switch to a higher power consumption state a motion sensing unit (not explicitly shown, for example, on the same carrier as the control unit and / or on a carrier closer to the distal end of the user interface member located at the bottom end of FIG. 7A ) or another motorized unit to switch the system to a second state with higher power consumption.

[0163] In the illustrated embodiment, the first and second portions 1603 and 1604 are formed by separately manufactured and assembled components. In the illustrated embodiment, the first and second portions are coupled to one another via a force-sensitive coupling 1690. The force-sensitive coupling 1690 preferably locks the first and second portions together, such that the first and second portions move, e.g., rotate, together unless a force greater than a predetermined threshold force, e.g., a force at which the coupling stabilizes, acts on the coupling. In this case, the threshold force may be greater than the normal forces encountered during dose setting and dose delivery. That is, during normal movement of a user interface member relative to the housing 10, e.g., for dose setting and / or dose delivery, the force-sensitive coupling is stable and capable of transmitting force or torque. In particular, when a force or torque below the threshold force or torque is applied, the first and second portions act as a single member. However, when a force or torque greater than the threshold force or torque is applied to the coupling, the coupling releases, allowing the first portion to move relative to the second portion. The force-sensitive coupling is preferably configured so that the first portion 1603 and the second portion 1604 rotate at the same speed unless a threshold force or torque is applied to the coupling. When this threshold force or torque is exceeded, the coupling can be released, allowing relative rotation between the first portion 1603 and the second portion 1604. In particular, the first portion 1603, which exhibits the setting surface 1610, can be rotated relative to the second portion 1604. This relative rotation can be used to trigger the signal transmission unit 1300 and provide a signal to switch the electronic system to a higher power consumption state. The force-sensitive coupling 1690 can be formed by the connection features of the first portion and the second portion interacting, e.g., engaging, to establish the force-sensitive coupling. The force-sensitive coupling 1690 is highly schematically illustrated in FIG. 7B by a protrusion on the first portion 1603 engaging a recess on the second portion 1604. However, it should be understood that further configurations are possible and this implementation is merely an example.

[0164] The force-sensitive coupling is preferably dimensioned so that a force or torque generated during a normal setting event is transmitted via the coupling from the user interface member 1600 to the dose setting and drive mechanism, for example, to the aforementioned member 3010 (see, e.g., FIG. 4A ) to which the user interface member can be connected. The force or torque transmitted via the force-sensitive coupling can be the force or torque required to rotate the user interface member 1600 in the dose setting direction until the dose is set, which in the illustrated configuration would be clockwise as viewed in a top view of the delivery surface 1620. Additionally, a force or torque for canceling or reducing a preset dose, which involves rotation in a direction opposite to the dose setting direction, is preferably transmitted via the force-sensitive coupling. That is, the first portion 1603 and the second portion 1604 are non-rotatably locked by the force-sensitive coupling for dose setting and canceling or reducing a preset dose. In the event of an activation operation, the force-sensitive coupling is released.

[0165] The force-sensitive coupling can transmit forces or associated torques less than or equal to 0.05 Nm or less than or equal to 0.04 Nm. The torque can be greater than 0.005 Nm. These forces or torques are typical of dose setting operations, such as setting a dose, adjusting a set dose, or canceling a set dose. Typical dial setting or setting forces or torques range from 0.014 Nm to 0.03 Nm, for example, for the device (unit) discussed in connection with FIG. 1 . Thus, when forces or torques within the specified region or range are applied to the setting surface, these forces or torques can be transmitted via the force-sensitive coupling without relative rotational movement of the first and second parts. When larger forces or torques are applied, this results in relative movement between the first and second parts.

[0166] To enable relative rotation between the first portion 1603 and the second portion 1604, the force sensitive connection 1690 can be released. The connection can only be released when a force or associated torque greater than or equal to one of the following values ​​acts on the force sensitive connection: 0.05 Nm, 0.06 Nm, 0.07 Nm, 0.08 Nm, 0.09 Nm, 0.1 Nm.

[0167] In the initial position of the user interface member (zero-dose position), where no dose has been set by the user, rotation of the user interface member 1600 in the direction opposite the dose setting direction relative to the housing 10 and / or another component or member of the drug delivery device can be prevented by a stop engagement. This engagement is often referred to as a zero-unit stop or zero-dose stop. In this embodiment, the stop engagement can be or is implemented via the second portion 1604 of the user interface member 1600 or a member connected to that portion, such as the member 3010 of the dose setting and drive mechanism. The stop engagement is shown highly diagrammatically in FIG. 7C , where a stop mechanism on the portion 1604 or member 3010 abuts against a corresponding stop mechanism that may be provided on the housing 10 or another component of the device that is non-rotatably locked to the housing 10 during or at least at the beginning of dose setting, against rotation in the direction opposite the dose setting direction. In this arrangement, the dose setting direction is clockwise, and the portion 1604 / member 3010 should be rotated away from the corresponding stop mechanism on the housing. A stop engagement can be established in the rest position of the first portion. When a user attempts to rotate the user interface member in the illustrated configuration in a direction opposite to the dose setting direction, i.e., counterclockwise, the second portion 1604 is prevented from following the rotation due to the stop engagement. Thus, if a user applies a force or torque through the setting surface 1610 and the user-applied force or torque exceeds a threshold force or torque that can be transmitted through the force-sensitive coupling 1690, the first portion 1603 will rotate relative to the second portion. This rotation can be used to trigger the switch 1685. Rotation of the first portion relative to the second portion, for example, away from the rest or zero dose position and / or in a direction opposite to the dose setting direction, can be limited, for example, by a rotation stop engagement, which can be formed by a feature on the first portion non-rotatably engaging a feature on the second portion (not explicitly shown).Because the second part cannot be rotated in a direction opposite to the dose setting direction, when the anti-rotation engagement is established the first part also cannot be rotated in that direction.

[0168] The first portion 1603 of the user interface member 1600 includes a trigger feature 1689. This feature is implemented in the illustrated embodiment as a protrusion, e.g., an axially oriented protrusion, such as a protrusion having a free distal end. This trigger feature can move relative to the switch 1685 when the first portion moves relative to the second portion, interacting with the switch directly (not shown) or indirectly through an additional feature to trigger the switch 1685. The first portion can be coupled to the second portion such that relative rotational movement of the first portion with respect to the second portion is translated into axial movement of the additional feature to trigger the switch.

[0169] In the illustrated embodiment, a flexible arm 1688, e.g., a trigger arm, is provided for triggering the switch 1685. The arm can be an additional feature that is axially displaced to trigger the switch. In the illustrated embodiment, the arm is fixedly connected to or integral with the second portion 1604. The arm can be angularly oriented. The arm 1688 is preferably displaceable or deformable, e.g., axially, to trigger the switch, e.g., via contact with the trigger feature 1687. The arm 1688 has a free end that defines the arm in a direction of rotation of the first portion 1603 relative to the second portion 1604 from a rest position to a signal transmitting position, e.g., a direction opposite to the dose setting direction. The arm 1688 is preferably designed to interact with the trigger feature 1687 of the switch 1685. When the first portion 1603 rotates toward the free end of the arm, counterclockwise in the illustrated configuration, the arm 1688 deflects axially, e.g., distally, thereby triggering the switch 1685.

[0170] The arm 1688 is preferably elastically displaceable, so that when the user releases the user interface member, an elastic restoring force can be used to re-establish its original position and / or re-establish the force-sensitive connection. That is, the bias can move the first portion toward its rest position relative to the second portion, thus re-establishing the initial state of the user interface member, for example, when the user releases the setting surface 1610. Alternatively, another biasing mechanism, for example, a separate spring mechanism, can be provided to re-establish the force-sensitive connection or the initial state. Also, triggering of the switch can be achieved by a different mechanism, such as directly via a trigger feature of the first portion, such as its trigger feature 1687, interacting with the switch. It will be appreciated that a structure can also be implemented in which the arm 1688 is fixedly connected to or integral with the first portion 1603.

[0171] After switch 1685 is triggered, a corresponding signal can be detected by electronic control unit 1100, which can issue a command to switch the motion sensing unit to a higher power consumption state, e.g., because a dose setting and / or dispensing operation is expected soon. That is, in this case, attempting to rotate the user interface member in a direction opposite to the dose setting direction when the user interface member is in the initial position can be used to generate a wake-up prompt or usage signal. If no movement is detected by the motion sensing unit within a predetermined time interval, e.g., 30 seconds, after the motion sensing unit has been switched to a higher power consumption state, the electronic system can be switched back to the state it previously had, e.g., switched off again, to avoid unnecessary power consumption.

[0172] In one embodiment, the electronic system is switched to a second state with higher power consumption only when the first part is away from the rest position, e.g., maintained in a signal transmission position, for a period greater than a predetermined time, e.g., greater than or equal to 3 seconds or greater than 5 seconds. Thus, the electronic control unit, or another unit of the system, can evaluate a time characteristic of a signal generated by the signal transmission unit, e.g., signal duration or the time between two consecutive signals. If this time characteristic meets a criterion indicating that the first part has been away from the rest position for a period greater than the predetermined time, the system can be switched to the second state. Using a predetermined time is particularly suitable for characterizing activation operations. The electronic control unit can issue a signal or command to switch the system to the second state, e.g., to activate the communication unit and / or the motion sensing unit, only if evaluation of the time characteristic indicates that the first part has been away from the rest position and / or in the signal transmission position for a period greater than the predetermined time. For example, the predetermined time can be used to distinguish between activation operations and dose operations. When a predetermined time is used, it facilitates that the force required for the activation action can be similar to or even less than the force required for a dose action, such as the force for a dose setting action. In this embodiment, the force that a user must apply to release the force-sensitive coupling by rotating it opposite to the dose setting direction can be the same as or less than the force required to set a dose by moving the first and second parts in the dose setting direction (in Figures 7A-7C, the setting direction is the direction for moving the first and second parts away from the signal transmitting position). The activation action can be used to manually trigger a synchronization action by the communication unit.

[0173] It should be noted that the described time-based approach is not limited to this embodiment and can be applied to other embodiments as well, especially when an activation action different from the dose action is used to trigger the system to switch to a state of higher power consumption. For example, the activation action can be, for example, in the configuration shown in Figures 4A-4H, when the delivery surface 1620 is pressed and held for a predetermined time with a force smaller than that required when, for example, a zero dose is set or to initiate a dose delivery action. The same applies to rotation opposite to the dose setting direction for the activation action, where the first part must be held away from the rest position for a predetermined time before the system switches to the second state. Alternatively or additionally, in Figures 4A-4H, if rotation opposite to the dose setting direction is used to generate a signal, for example, for an activation action and / or at the zero dose setting position, the force for this can be similar to that for dose setting. The angle of rotation required to generate a signal can be greater than the angle corresponding to one unit setting increment, and / or can be greater than or equal to 10°, 15°, 17°, 20°. Having a larger angle of rotation reduces the likelihood of accidentally generating a signal.

[0174] The terms "drug" or "medicament" are used interchangeably herein to describe a pharmaceutical formulation containing one or more active pharmaceutical ingredients or pharmaceutically acceptable salts or solvates thereof, and optionally a pharmaceutically acceptable carrier. An active pharmaceutical ingredient ("API"), in its broadest sense, is a chemical structure that has a biological effect on humans or animals. In pharmacology, drugs or medications are used to treat, cure, prevent, or diagnose disease or otherwise improve physical or mental well-being. Drugs or medications can be used for a limited duration or periodically for chronic disorders.

[0175] As described below, drugs or pharmaceutical agents may contain at least one API or a combination thereof in various types of formulations for the treatment of one or more diseases. Examples of APIs include small molecules with a molecular weight of 500 Da or less, polypeptides, peptides, and proteins (e.g., hormones, growth factors, antibodies, antibody fragments, and enzymes), carbohydrates and polysaccharides, as well as nucleic acids, double-stranded or single-stranded DNA (including naked and cDNA), RNA, antisense nucleic acids, such as antisense DNA and RNA, small interfering RNA (siRNA), ribozymes, genes, and oligonucleotides. Nucleic acids can be incorporated into molecular delivery systems such as vectors, plasmids, or liposomes. Mixtures of one or more drugs are also contemplated.

[0176] The drug or agent can be contained in a primary package or "drug container" adapted for use in a drug delivery device. The drug container can be, for example, a cartridge, syringe, reservoir, or other rigid or flexible vessel configured to provide a chamber suitable for storage (e.g., short-term or long-term storage) of one or more drugs. For example, in some cases, the chamber can be designed to store the drug for at least one day (e.g., from one day to at least 30 days). In some cases, the chamber can be designed to store the drug for about one month to about two years. Storage can occur at room temperature (e.g., about 20°C) or refrigerated temperatures (e.g., from about -4°C to about 4°C). In some cases, the drug container can be or include a dual-chamber cartridge configured to separately store two or more components of a pharmaceutical formulation to be administered (e.g., an API and a diluent, or two different drugs), one in each chamber. In such cases, the two chambers of the dual-chamber cartridge can be configured to allow mixing between two or more components prior to and / or during administration to the human or animal body. For example, the two chambers can be configured to be in fluid communication with each other (e.g., via a conduit between the two chambers) and to allow mixing of the two components by a user, if desired, prior to administration. Alternatively or additionally, the two chambers can be configured to allow mixing upon administration of the components to the human or animal body.

[0177] The drugs or agents contained in the drug delivery devices described herein can be used to treat and / or prevent many different types of medical disorders. Examples of disorders include, for example, diabetes or complications associated with diabetes, such as diabetic retinopathy, and thromboembolic disorders, such as deep vein thromboembolism or pulmonary embolism. Further examples of disorders include acute coronary syndrome (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis, and / or rheumatoid arthritis. Examples of APIs and drugs are those listed in handbooks such as Rote Liste 2014 (e.g., but not limited to, Main Group 12 (antidiabetic agents) or 86 (oncology agents)) and the Merck Index, 15th edition.

[0178] Examples of APIs for the treatment and / or prevention of type 1 or type 2 diabetes or complications associated with type 1 or type 2 diabetes include insulin, e.g., human insulin, or a human insulin analog or derivative; glucagon-like peptide (GLP-1), a GLP-1 analog or GLP-1 receptor agonist, or an analog or derivative thereof; a dipeptidyl peptidase-4 (DPP4) inhibitor; or a pharmaceutically acceptable salt or solvate thereof, or any mixture thereof. As used herein, the terms "analog" and "derivative" refer to a polypeptide having a molecular structure that is formally derivable from the structure of a naturally occurring peptide, e.g., the structure of human insulin, by deletion and / or replacement of at least one amino acid residue present in the naturally occurring peptide and / or by addition of at least one amino acid residue. The added and / or replaced amino acid residue can be either a codable amino acid residue, another naturally occurring residue, or a purely synthetic amino acid residue. Insulin analogs are also referred to as "insulin receptor ligands." In particular, the term "derivative" refers to a polypeptide having a molecular structure formally derivable from the structure of a naturally occurring peptide, for example, the molecular structure of human insulin in which one or more organic substituents (e.g., fatty acids) are attached to one or more of the amino acids. Optionally, one or more amino acids present in the naturally occurring peptide are deleted and / or replaced by other amino acids, including non-codable amino acids, or amino acids, including non-codable ones, are added to the naturally occurring peptide.

[0179] Examples of insulin analogues are Gly(A21), Arg(B31), Arg(B32) human insulin (insulin glargine); Lys(B3), Glu(B29) human insulin (insulin glulisine); Lys(B28), Pro(B29) human insulin (insulin lispro); Asp(B28) human insulin (insulin aspart); human insulin in which the proline at position B28 is replaced by Asp, Lys, Leu, Val or Ala and the Lys at position B29 may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.

[0180] Examples of insulin derivatives are, for example, B29-N-myristoyl-des(B30) human insulin, Lys(B29)(N-tetradecanoyl)-des(B30) human insulin (insulin detemir, Levemir®); B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoylLysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin. B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-gamma-glutamyl)-des(B30) human insulin, B29-N-omega-carboxypentadecanoyl-gamma-L-glutamyl-des(B30) human insulin (insulin degludec, Tresiba®); B29-N-(N-lithocholyl-gamma-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.

[0181] Examples of GLP-1, GLP-1 analogs and GLP-1 receptor agonists are, for example, lixisenatide (Lyxumia®), exenatide (exendin-4, Byetta®, Bydureon®, a 39 amino acid peptide produced by the salivary glands of the flathead monster), liraglutide (Victoza®), semaglutide, taspoglutide, albiglutide (Syncria®), dulaglutide (Trulicity®), rexendin-4, CJC-1134-PC, PB-1023, TTP-054, langrenatide / HM-11260C (efpegrenatide). , HM-15211, CM-3, GLP-1 Erigen, ORMD-0901, NN-9423, NN-9709, NN-9924, NN-9926, NN-9927, Nodexene, Viador-GLP-1, CVX-096, ZYOG-1, ZYD-1, GSK-2374697, DA-3091, MAR-701, MAR709, ZP-2929, ZP-3022, ZP -DI-70, TT-401 (Pegapamodtide), BHM-034, MOD-6030, CAM-2036, DA-15864, ARI-2651, ARI-2255, Tirzepatide (LY3298176), Bamadutide (SAR425899), Exenatide-XTEN, and Glucagon-Xten.

[0182] Examples of oligonucleotides are, for example, the cholesterol-lowering antisense therapeutic mipomersen sodium (Kynamro®) for the treatment of familial hypercholesterolemia, or RG012 for the treatment of Alport syndrome.

[0183] Examples of DPP4 inhibitors are linagliptin, vidagliptin, sitagliptin, denagliptin, saxagliptin, berberine.

[0184] Examples of hormones include pituitary or hypothalamic hormones or regulatory active peptides and their antagonists, such as gonadotropins (follitropin, lutropin, chorion gonadotropin, menotropin), somatropine (somatropin), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin, and goserelin.

[0185] Examples of polysaccharides include glycosaminoglycans, hyaluronic acid, heparin, low-molecular-weight heparin or ultra-low-molecular-weight heparin or derivatives thereof, or sulfated polysaccharides, such as the polysulfated forms of the aforementioned polysaccharides, and / or pharmaceutically acceptable salts thereof. An example of a pharmaceutically acceptable salt of polysulfated low-molecular-weight heparin is enoxaparin sodium. Examples of hyaluronic acid derivatives include Hylan G-F20 (Synvisc®) and sodium hyaluronate.

[0186] As used herein, the term "antibody" refers to an immunoglobulin molecule or an antigen-binding portion thereof. Examples of antigen-binding portions of immunoglobulin molecules include F(ab) and F(ab')2 fragments that retain antigen-binding ability. An antibody can be a polyclonal antibody, a monoclonal antibody, a recombinant antibody, a chimeric antibody, a deimmunized or humanized antibody, a fully human antibody, a non-human (e.g., murine) antibody, or a single-chain antibody. In some embodiments, an antibody has effector function and is capable of fixing complement. In some embodiments, an antibody has reduced or no binding ability to Fc receptors. For example, an antibody can be an isotype or subtype, antibody fragment, or mutant that does not support Fc receptor binding, e.g., has a mutation or deletion of the Fc receptor binding region. The term antibody also includes antigen-binding molecules based on tetravalent bispecific tandem immunoglobulins (TBTIs) and / or dual variable region antibody-like binding proteins (CODVs) with a crossover binding region orientation.

[0187] The term "fragment" or "antibody fragment" refers to a polypeptide (e.g., an antibody heavy and / or light chain polypeptide) derived from an antibody polypeptide molecule that does not include the full-length antibody polypeptide but comprises at least a portion of the full-length antibody polypeptide that is still capable of binding to antigen. Antibody fragments can include truncated portions of a full-length antibody polypeptide, but the term is not limited to such truncated fragments. Antibody fragments useful in the present invention include, for example, Fab fragments, F(ab')2 fragments, scFv (single-chain Fv) fragments, linear antibodies, monospecific or multispecific antibody fragments, e.g., bispecific, trispecific, tetraspecific, and multispecific antibodies (e.g., diabodies, triabodies, tetrabodies), monovalent or multivalent antibody fragments, e.g., bivalent, trivalent, tetravalent, and multivalent antibodies, minibodies, chelating recombinant antibodies, tribodies or bibodies, intrabodies, nanobodies, small modular immunopharmaceuticals (SMIPs), binding domain immunoglobulin fusion proteins, camelized antibodies, and VHH-containing antibodies. Additional examples of antigen-binding antibody fragments are known in the art.

[0188] The term "complementarity determining region" or "CDR" refers to short polypeptide sequences within the variable regions of both heavy and light chain polypeptides that are primarily responsible for mediating specific antigen recognition. The term "framework region" refers to amino acid sequences within the variable regions of both heavy and light chain polypeptides that are not CDR sequences and that are primarily responsible for maintaining the proper orientation of the CDR sequences to enable antigen binding. Although the framework regions themselves typically do not directly participate in antigen binding, as is known in the art, certain residues within the framework regions of a particular antibody may be directly involved in antigen binding or may affect the ability of one or more amino acids within the CDRs to interact with the antigen.

[0189] Examples of antibodies are anti-PCSK-9 mAb (e.g., alirocumab), anti-IL-6 mAb (e.g., sarilumab), and anti-IL-4 mAb (e.g., dupilumab).

[0190] Pharmaceutically acceptable salts of any of the APIs described herein are contemplated for use as drugs or medicaments in drug delivery devices. Pharmaceutically acceptable salts include, for example, acid addition salts and base salts.

[0191] It will be understood by those skilled in the art that modifications (additions and / or deletions) can be made to the various components of the APIs, formulations, apparatus, methods, systems, and embodiments described herein without departing from the full scope and spirit of the invention, and that the invention encompasses such modifications and all equivalents thereof.

[0192] Exemplary drug delivery devices include needle-based injection systems as described in Table 1 of Chapter 5.2 of ISO 11608-1:2014(E). As described in ISO 11608-1:2014(E), needle-based injection systems can be broadly distinguished into multi-dose container systems and single-dose (partially or fully expelled) container systems. The container can be an interchangeable container or an integrated, non-interchangeable container.

[0193] As further described in ISO 11608-1:2014(E), a multi-dose container system can include a needle-based injection device with replaceable containers. In such a system, each container holds multiple doses, and the dose size can be fixed or variable (pre-set by the user). Another multi-dose container system can include a needle-based injection device with an integrated, non-replaceable container. In such a system, each container holds multiple doses, and the dose size can be fixed or variable (pre-set by the user).

[0194] As further described in ISO11608-1:2014(E), a single-dose container system can include a needle-based injection device with replaceable containers. In one example for such a system, each container holds a single dose, thereby discharging the entire deliverable volume (full discharge). In a further example, each container holds a single dose, thereby discharging a portion of the deliverable volume (partial discharge). Also as described in ISO11608-1:2014(E), a single-dose container system can include a needle-based injection device with an integrated, non-replaceable container. In one example for such a system, each container holds a single dose, thereby discharging the entire deliverable volume (full discharge). In a further example, each container holds a single dose, thereby discharging a portion of the deliverable volume (partial discharge).

[0195] The scope of protection is not limited to the examples set forth herein above: the invention disclosed herein embodies each and every novel feature and each combination of features, and such features specifically include all combinations of features recited in the claims, even if that feature or combination of features is not explicitly recited in the claims or examples. [Explanation of symbols]

[0196] 1. Injection device, drug delivery device, or device unit 10. Housing 12 Dosage Knob 11 Injection button 13. Windows 14 Container 15 needles 16 Inner needle cap 17 Outer needle cap 18 Cap 70 Dial or Number Sleeve 71a~71c formations 1000 Electronic Systems 1100 Electronic Control Unit 1200 Motion Sensing Unit 1300 Signal Transmitting Unit 1310 Switch 1400 Communication Unit 1500 power supply 1600 User interface components 1601 Materials 1602 Materials 1603 parts 1604 parts 1605 User interface member body 1606 Connection part 1607 Space 1608 Guidance function 1609 Guidance function 1610 Setting screen 1613 Axis 1615 Connectivity 1620 Delivery surface 1650 Delivery Switch 1655 Interface Function 1657 Trigger Function 1660 setting switch 1665 Interface Function 1667 Trigger Function 1670 area 1675 Space 1680 area 1685 Switch 1687 Trigger Function 1688 Arm 1689 Trigger Function 1690 Force-sensitive connection 3000 Conductor Carrier 3005 Conductor Carrier 3010 Materials 3020 Interface 3030 Space

Claims

1. An electronic system (1000) for a drug delivery device (1), comprising: at least one user interface member (1600) configured to be operated by a user to perform a dose operation, such as a dose setting operation for setting a dose of a drug to be delivered by the drug delivery device and / or a dose delivery operation for delivering the set dose; an electronic control unit (1100) configured to control an operation of the electronic system, the electronic system having a first state and a second state, the electronic system having a higher power consumption in the second state compared to the first state; and an electrical signal transmitting unit (1300) configured to provide an electrical signal indicative of a user interface member being operated, wherein: the electronic control unit is configured to switch the electronic system from a first state to a second state in response to an electrical signal; The user interface member includes a first portion (1603) and a second portion (1604), the first portion being movable relative to the second portion from a rest position of the first portion to a signal transmitting position of the first portion, and the signal transmitting unit is configured to provide an electrical signal in response to movement of the first portion relative to the second portion from the rest position to the signal transmitting position.

2. the movement of the first portion (1603) from the rest position to the signal transmitting position is accompanied by a rotational movement of the first portion relative to the second portion; and / or The electronic control unit (1100) is connected to the second part. The electronic system of claim 1 .

3. the first portion (1603) and the second portion (1604) are permanently and directly mechanically interconnected by a mechanical interconnection (1606, 1690) during dose operation; 3. An electronic system according to claim 1 or 2.

4. The mechanical interconnection includes at least one joint integrally formed with the first portion and the second portion. A follow-up function (1606) may be included. the connecting feature (1606) is flexible to allow movement of the first portion (1603) relative to the second portion (1604) from a rest position to a signal transmitting position; The electronic system according to any one of claims 1 to 3.

5. the mechanical interconnection includes at least one connection feature (1689) of the first portion (1603) and at least one connection feature (1688) of the second portion (1604) that interact with each other to establish a mechanical interconnection (1690); 4. The electronic system of claim 3.

6. the mechanical interconnection (1690) is releasable to perform an actuation action involving movement of the first portion (1603) from a rest position to a signal transmission position, the actuation action being distinct from a dose action; 6. The electronic system of claim 5.

7. the mechanical interconnection (1690) is configured such that a force or torque that a user must apply to the first portion (1603) by the user interface member (1600) to perform a dose operation is less than a force or torque that a user must apply to the first portion to move the first portion from a rest position to a signal transmitting position; 7. An electronic system according to claim 5 or 6.

8. the second portion (1604) is configured to abut a stop mechanism when the first portion is moved from the rest position toward the signal transmitting position; and / or The rest position is a non-dose set position. An electronic system according to any one of the preceding claims.

9. the signal transmission unit (1300) includes an electrical switch mechanism configured to be triggered and provide an electrical signal when the first portion (1603) is moved from a rest position to a signal transmission position relative to the second portion (1604); An electronic system according to any one of the preceding claims.

10. the electronic system (1000) is configured such that the electronic system is switched from the first state to the second state only when the first portion of the user interface member is held away from a rest position for a period of time that exceeds a predetermined period of time; and / or The electronic system (1000) is configured as an accessory module for the drug delivery device unit (1), An electronic system according to any one of the preceding claims.

11. When the first portion (1603) is in the signal transmitting position, the first portion is biased toward the rest position by a biasing mechanism (1688) of the user interface member (1600). An electronic system according to any one of the preceding claims.

12. the first portion and the second portion are connected via a force sensitive connection; and / or the system is configured such that the first portion is connected to the second portion to withstand a torque and / or force after relative movement away from the rest position, e.g., into or beyond the signal transmission position, is completed; An electronic system according to any one of the preceding claims.

13. An electronic system comprises the following units or components: Electrokinetic sensing unit; A communication unit; Memory Unit The electronic system of any one of claims 1 to 12, comprising at least one, an arbitrarily selected plurality, or all of:

14. An electronic system according to any one of the preceding claims, wherein when in a rest position the first part is movable in two different directions relative to the second part, for example in both rotational directions.

15. A drug delivery device comprising an electronic system according to any one of claims 1 to 14 and a reservoir containing a drug.